# GLP Loss

> Independent reviews of GLP-1 telehealth sellers — semaglutide and tirzepatide, compounded and brand. We read the standing monthly rate off each seller's own page, not the prepay figure it leads with.

GLP Loss reviews the companies selling GLP-1 online — compounded
semaglutide and tirzepatide, by injection and in oral preparations — and scores them on
price transparency, how a price behaves across the dose ladder, and access.
Independent: no parent company, no sponsored rankings.

## The single most important thing to know about buying GLP-1 online

**The drugs work; what most of these sellers dispense is not the approved drug.
Compounded semaglutide and tirzepatide are not FDA-approved and are not
reviewed by the FDA for safety, efficacy or quality before they reach you.**

- **What the molecules are.** Semaglutide is a GLP-1 receptor agonist;
  tirzepatide is a dual GIP/GLP-1 receptor agonist. Both are given as a
  once-weekly subcutaneous injection and are titrated upward over several
  months. Oral semaglutide exists as an approved tablet, and several sellers
  on this site also compound their own oral preparations.
- **Approved products exist, under brand names.** Semaglutide is approved as
  Wegovy and Ozempic, and tirzepatide as Zepbound and Mounjaro. Those are the
  products the trials below studied. A compounded preparation bought from a
  telehealth seller is a different thing: it may contain the same molecule,
  but it has not been through the review those brands went through, and its
  strength and purity are the compounding pharmacy's responsibility rather
  than the FDA's.
- **Efficacy — semaglutide.** STEP 1 randomized 1,961 adults with overweight or
  obesity to once-weekly semaglutide 2.4 mg or placebo for 68 weeks. Mean
  change in body weight was −14.9% against −2.4% on placebo (PMID 33567185,
  N Engl J Med 2021).
- **Efficacy — tirzepatide.** SURMOUNT-1 randomized 2,539 adults for 72 weeks;
  mean weight reduction reached −20.9% at the 15 mg dose against −3.1% on
  placebo (PMID 35658024, N Engl J Med 2022). SURMOUNT-5 directly compared the two in adults with obesity without diabetes
  at their maximum tolerated doses. At 72 weeks, mean weight reduction was
  20.2% with tirzepatide and 13.7% with semaglutide (PMID 40353578,
  N Engl J Med 2025). These are results for the studied approved medicines,
  not compounded preparations.
- **Outcomes beyond weight.** SELECT followed 17,604 adults with
  cardiovascular disease and obesity but without diabetes, and reported fewer
  major adverse cardiovascular events on semaglutide than on placebo
  (PMID 37952131, N Engl J Med 2023). This is a far larger and more recent
  evidence base than most telehealth categories can point to.
- **It comes back when you stop, and both drugs have shown this.** In STEP 4,
  participants switched to placebo regained weight over the following year
  (PMID 33755728, JAMA 2021); SURMOUNT-4 found the same pattern after
  tirzepatide withdrawal (PMID 38078870, JAMA 2024). A price is therefore an
  ongoing price, which is why this site ranks on the standing monthly rate
  rather than on an introductory one.

The claims worth treating skeptically here are not about whether the drugs
work — they do, on the evidence above. They are about what a compounded
product actually contains, what a "microdose" protocol is based on, and what
the advertised monthly figure will really cost you in month two.

## Three findings from our own provider sweep

**1. Oral GLP-1 is not reliably the cheap format.** Across 91 usable
advertised oral/injection quote pairs, matched within the same seller,
molecule and compounded supply, 75 differ and 45 have the higher
oral quote. These are product comparisons, not counts of distinct sellers.
A buyer comparing formats should compare the two quotes for the same molecule
and seller, with the supply and renewal terms attached.

**2. Molecule and preparation both matter.** Among the providers with published
editorial coverage, published monthly comparison amounts for compounded semaglutide span
$76–$399/month by injection and $99–$599/month orally. Compounded
tirzepatide quotes span $86–$499/month by injection and
$119–$434/month orally. These are separate, scoped monthly-comparison ranges, including longer-term payment equivalents,
not verified checkout totals. They exclude branded products, unavailable
quotes and rows marked promotional or non-monthly. Package, dose and renewal
conditions still apply; see the individual review before comparing a bill.

**3. An advertised price may have conditions.** Prices here are published
seller figures with their stated terms, not checkout-verified bills. Some
quotes require prepayment, apply only to a starting dose, or leave renewal
costs unclear; the review records those limits.
Confirm the renewal rate and required upfront payment before enrolling.

## How our rankings work

Scores are computed from a published rubric — price transparency, honest headline, dose-ladder pricing, access — and are
**blind to whether we earn a commission**. Commercial relationships set display
order on category pages, never the score, and every paid placement is labeled.
27 of 471 sellers we cover are current partners: 27 are wired to a GLP-1 destination and appear labeled Partner, sorted first on their board; every other outbound link on this site remains editorial.
Methodology: https://glploss.com/methodology

## Complete page directory (802)

Every canonical, indexable page from the production build is included below,
including research, provider reviews, comparisons, rankings, tools, profiles
and other information pages. Descriptions summarize the source page; follow
its canonical link for the evidence, product scope and qualifications.

- [GLP Loss | What a GLP-1 actually costs per month.](https://glploss.com): Independent reviews of GLP-1 telehealth sellers — semaglutide and tirzepatide, compounded and brand. We read the standing monthly rate off each seller's own page, not the prepay figure it leads with.
- [About | GLP Loss](https://glploss.com/about): GLP Loss is an independent review site for GLP-1 sellers, written by an editorial team and funded by affiliate commission. Here's how it works.
- [Our Team | GLP Loss](https://glploss.com/authors): Meet the GLP Loss editorial team covering provider pricing, treatment evidence and editorial standards.
- [GLP Loss Editorial — Publisher | GLP Loss](https://glploss.com/authors/glp-loss-editorial): Source-based reporting from GLP Loss, an affiliate-funded health information publisher. Some GLP Loss provider comparisons and explanations of GLP-1 research use this organization byline.
- [Hana Brennan — Pricing & provider data | GLP Loss](https://glploss.com/authors/hana-brennan): Examines published plan tables, recurring charges and the terms behind advertised prices. Hana signs the reviews, the boards and the pricing work.
- [Owen Castellanos — Evidence & trials | GLP Loss](https://glploss.com/authors/owen-castellanos): Reads the trial, not the landing page — and says plainly where a protocol has no evidence behind it. Owen signs the research desk, covering the clinical literature on semaglutide, tirzepatide and the rest of the incretin class.
- [Tessa Whitfield — Editor | GLP Loss](https://glploss.com/authors/tessa-whitfield): Owns the standard: how a price gets verified, and what happens when it turns out wrong. Tessa edits the site and owns the methodology and corrections pages.
- [Buyer's guides | GLP Loss](https://glploss.com/best): Every GLP Loss buyer's guide in one place — compounded semaglutide and tirzepatide, oral GLP-1, flat-dose pricing and the cheapest standing monthly rates. Ranked by molecule, by price and by who is asking. Affiliate-disclosed.
- [Cheapest GLP-1: The Lowest Published Monthly Prices | GLP Loss](https://glploss.com/best/cheapest-glp1): GLP-1 telehealth sellers ordered by the lowest published monthly quote they publish across semaglutide and tirzepatide — introductory offers excluded, not ranked first.
- [Best Compounded Semaglutide: Published Prices Compared | GLP Loss](https://glploss.com/best/compounded-semaglutide): Compare published semaglutide injection prices, dose policies, and provider terms. Check required fees and pharmacy details before choosing a plan.
- [Best Compounded Tirzepatide: Published Prices Compared | GLP Loss](https://glploss.com/best/compounded-tirzepatide): Compare published tirzepatide injection prices, dose policies, and provider terms. Confirm fees, pharmacy information, and payment requirements before subscribing.
- [GLP-1 Providers With Flat Pricing Across Every Dose | GLP Loss](https://glploss.com/best/flat-dose-pricing): Sellers that hold one monthly price as your dose escalates, rather than re-pricing at each titration step — compare the stated dose policy, plan terms, and required fees.
- [Oral GLP-1 Options: What the Pill Actually Costs | GLP Loss](https://glploss.com/best/oral-glp1): Sellers offering oral semaglutide and tirzepatide, priced against their own injectable rates — the tablet is routinely marketed as the cheaper route and frequently is not.
- [Oral Semaglutide: Every Seller and What the Tablet Costs | GLP Loss](https://glploss.com/best/oral-semaglutide): Sellers compounding semaglutide as a tablet or dissolvable, each priced on its own oral figure rather than its injection rate — the gap runs in both directions at the same seller.
- [Oral Tirzepatide: Every Seller and What the Tablet Costs | GLP Loss](https://glploss.com/best/oral-tirzepatide): Compare providers offering compounded oral tirzepatide, their published quotes, formulation details, and the limits of evidence from injectable trials.
- [Best Semaglutide for Men: What Actually Differs | GLP Loss](https://glploss.com/best/semaglutide-for-men): There is no men's semaglutide — the evidence shows no outcome difference by sex. What differs is what a men's-health storefront bundles alongside it, and what that bundle costs.
- [Best Semaglutide for Women: What Actually Differs | GLP Loss](https://glploss.com/best/semaglutide-for-women): There is no women's semaglutide — the evidence shows no outcome difference by sex. What does differ is one drug interaction, and the pricing variables that decide what a year costs.
- [Compounded Semaglutide Under $150 a Month | GLP Loss](https://glploss.com/best/semaglutide-under-150): Compare published compounded semaglutide injection quotes under $150 per month. Check dose limits, required payment, additional fees, and renewal terms.
- [Best Tirzepatide for Women: the One Interaction That Matters | GLP Loss](https://glploss.com/best/tirzepatide-for-women): There is no women's tirzepatide. What is specific to this molecule is an oral-contraceptive interaction semaglutide does not carry — and it changes what you do in the first four weeks.
- [Compounded Tirzepatide Under $250 a Month | GLP Loss](https://glploss.com/best/tirzepatide-under-250): Compare published compounded tirzepatide injection quotes under $250 per month. Check dose limits, required payment, additional fees, and renewal terms.
- [Code of Conduct | GLP Loss](https://glploss.com/code-of-conduct): GLP Loss's editorial code of conduct: no fabrication of data or citations, a strict conflicts-of-interest policy, an accuracy commitment, and an advertiser-influence prohibition on editorial verdicts.
- [Compare GLP-1 sellers head to head | GLP Loss](https://glploss.com/compare): Direct comparisons of GLP-1 sellers — what each one charges, which formats they ship, and who each is actually the better pick for.
- [Aspen vs Bionomy Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/aspen-health-vs-bionomy-health): Ten dollars apart on the sticker, and the money that actually differs sits outside it: one bundles an ingredient you did not pick, the other proposes extras.
- [Bayan Health vs NuuVim: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/bayan-health-vs-nuuvim): Neither of these is a month you can walk away from after thirty days, and the lower figure buys a deliberately smaller protocol rather than the standard dose.
- [BetterMe Rx vs Midi Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/betterme-rx-vs-midi-health): One of these is a rung on a published ladder with a milligram printed beside it; the other is a sale price that moves when the sitewide sale does.
- [Bodybuilding Health+ vs Synergy Rx: which GLP-1 seller is right for you?](https://glploss.com/compare/bodybuilding-health-plus-vs-synergy-rx): Twenty dollars a month separates these two on compounded semaglutide. Both state fifty-state coverage; the clearer difference is injections alone versus a wider choice of formulations.
- [Breeze Meds vs Direct Meds: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/breeze-meds-vs-direct-meds): Breeze Meds carries the lower headline, yet on the tablet specifically it is Direct Meds that comes in $50 under.
- [Breeze Meds vs Eden: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/breeze-meds-vs-eden): A dollar apart on the semaglutide sticker, and the thing you cannot pin down is a different thing at each.
- [Breeze Meds vs HumeCare+: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/breeze-meds-vs-humecare): Breeze Meds' tablet bundles are the tell: $899 for three months and $1,799 for six both work out fractionally above its own monthly figure.
- [Care Bare Rx vs Breeze Meds: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/care-bare-rx-vs-breeze-meds): Same entry price, same four named pharmacies — the split shows up the moment you ask what tirzepatide costs.
- [CeliaRx vs DoctorAdam: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/celia-rx-vs-doctoradam): One of these figures is a single charge for a bottle with no month in it; the other is a monthly rate sitting exactly on its own catalog's stated floor.
- [CoreAge Rx vs HealthRX: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/coreage-rx-vs-healthrx): HealthRX's year and CoreAge's month arrive at the same annual total, which turns this into a question about when the money leaves your account.
- [Direct Meds vs Embody: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/direct-meds-vs-embody): Direct Meds identifies its oral option as sublingual drops. Embody's current terms describe gum, and its older oral price is no longer a reliable basis for a $20 comparison.
- [Direct Meds vs Found: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/direct-meds-vs-found): The gap in the table below belongs to a prepaid year. Pay either of these by the month and $128 becomes $8.
- [DoctorAdam vs BetterMe Rx: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/doctoradam-vs-betterme-rx): Neither of these prices is a ceiling: one climbs with every dose step, and the other is a discount under a clock that restarts every three days.
- [Edessa vs Idgie Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/edessa-vs-idgie-health): Idgie's tablet carries a second drug its price card never names, so part of the $58 between these two is buying a different formulation.
- [Embody vs Strut Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/embody-vs-strut-health): Strut Health publishes an oral-tablet rate; Embody's current oral program needs a fresh quote before the two can be compared on price.
- [Enhance MD vs Live Vital: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/enhance-md-vs-live-vital): Neither of these sells a calendar month: one bills every four weeks and keeps going, the other sells seventy days and ends.
- [Gala vs Pallas Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/gala-vs-pallas-health): Pallas Health's tirzepatide arrives as $897 every twelve weeks after a $179 opener; Gala's is a yearly rate for doses below the trial schedule.
- [He & She MD vs Care Bare Rx: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/he-and-she-md-vs-care-bare-rx): He & She MD strikes through $199 to advertise $99. Care Bare Rx charges the $199 — and neither figure is a quote for one month of one drug.
- [HealthRX vs Trimi Health: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/healthrx-vs-trimi-health): The recorded semaglutide annual-plan totals match at $1,188. HealthRX also lists shorter plans; choosing between them requires comparing the upfront commitment and cancellation terms.
- [HumeCare+ vs Direct Meds: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/humecare-vs-direct-meds): HumeCare+ markets a medication, body-scan and app bundle. Direct Meds' recorded offer centers on medication and a published starting-dose schedule; the bundle's stated value is not a measured saving.
- [Live Vital vs Apex MD: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/live-vital-vs-apex-md): These quotes cover different offers: Live Vital's fixed ten-week block and Apex MD's semaglutide preparation with added ingredients.
- [Midi Health vs Curex: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/midi-health-vs-curex): Only one of these two will name the molecule on its pricing page, and only one publishes an ongoing tirzepatide rate at all — they are not the same one.
- [NuuVim vs Tru2u: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/nuuvim-vs-tru2u): One of these sellers publishes the rate it does not advertise; the other does not sell the medication it prices, and says so in its own terms.
- [Oak vs Care Bare Rx: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/oak-vs-care-bare-rx): Dose pricing is contradicted on both of these sites, and only one of them tells you how much a step up costs.
- [Oak vs He & She MD: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/oak-vs-he-and-she-md): Oak's recorded checkout did not match its advertised $119, $167 and $190 entry figures. He & She MD's $99 is a monthly equivalent on an upfront annual payment.
- [Sesame Care vs Collective: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/sesame-care-vs-collective): For semaglutide injections, Sesame offers branded Wegovy while Collective offers a compounded preparation. Both add a required access charge, so the medication headline is not the full bill.
- [SkinnyRx vs Bodybuilding Health+: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/skinnyrx-vs-bodybuilding-health-plus): Bodybuilding Health+ is $90 a month under SkinnyRx on injectable tirzepatide, and stays under it at every plan length either one publishes.
- [SkinnyRx vs Synergy Rx: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/skinnyrx-vs-synergy-rx): SkinnyRx's $199 sublingual semaglutide quote is not its tablet price. Comparing oral options requires checking the preparation as well as the recurring charge.
- [Strut Health vs Apex MD: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/strut-health-vs-apex-md): Strut Health quotes its oral semaglutide on auto-refill; Apex MD lists month-to-month billing. The price gap alone does not explain the difference in service.
- [Strut Health vs Enhance MD: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/strut-health-vs-enhance-md): Enhance MD's first fill is $112 with a code, which puts month one below Strut Health's standing rate and reverses the order here exactly once.
- [Strut Health vs Live Vital: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/strut-health-vs-live-vital): Two figures conditional in opposite directions: one is low because it repeats, the other because it ends after seventy days.
- [Synergy Rx vs Oak: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/synergy-rx-vs-oak): Neither opening charge is the rate you keep paying: one first month is discounted, the other is the bottom of a ladder that climbs.
- [Tru2u vs GetRelief Rx: which GLP-1 seller is right for you? | GLP Loss](https://glploss.com/compare/tru2u-vs-getrelief-rx): The gap between these two is small enough to ignore, and it would not matter anyway: only one of the two figures has a period attached to it.
- [Contact GLP Loss | GLP Loss](https://glploss.com/contact): How to reach GLP Loss — corrections, provider and pricing updates, press, and partnership enquiries, each with a direct route.
- [Corrections Policy | GLP Loss](https://glploss.com/corrections): GLP Loss's corrections policy: how to report an error, how we evaluate it, and how corrections are logged, dated, and disclosed on the affected page.
- [Disclosures | GLP Loss](https://glploss.com/disclosures): How GLP Loss earns revenue, our FTC affiliate disclosure under 16 CFR Part 255, and the firewall between commercial partnerships and editorial verdicts.
- [Editorial Policy | GLP Loss](https://glploss.com/editorial-policy): How GLP Loss sources clinical claims, verifies them against primary literature, handles corrections, and keeps editorial calls independent of advertisers.
- [Medical Disclaimer | GLP Loss](https://glploss.com/medical-disclaimer): GLP Loss is not medical advice. Compounded GLP-1 is not FDA-approved. Read this before making any decision based on content here.
- [Methodology | GLP Loss](https://glploss.com/methodology): Every score on GLP Loss is computed from a published rubric — evidence, price transparency, real monthly cost, formats, and prescribing process. Scores never move with commission.
- [Nature of Reviews | GLP Loss](https://glploss.com/nature-of-reviews): How GLP Loss assesses providers and products: the editorial criteria we use, why no provider can pay for a favorable verdict, and how monetized partners are labeled and ordered.
- [Privacy Policy | GLP Loss](https://glploss.com/privacy): How GLP Loss collects, uses, and protects your information, including our opt-out analytics, GDPR, and CCPA/CPRA practices.
- [Research | GLP Loss](https://glploss.com/research): Evidence reviews of the GLP-1 drugs sold online — semaglutide, tirzepatide and what is coming next. Every claim traced to the trial that produced it.
- [503A vs 503B: Two Rulebooks, One Word | GLP Loss](https://glploss.com/research/503a-vs-503b-pharmacies): 503A pharmacies and 503B outsourcing facilities: the exemptions each gets, where the bulk powder may come from, what the label must state, and who inspects.
- [ACHIEVE-1 Explained: Where the Oral GLP-1 Curve Stops | GLP Loss](https://glploss.com/research/achieve-1-trial-explained): ACHIEVE-1's design, preregistered endpoint and limits: two disagreeing dose-response curves, two estimands producing two sets of numbers, and why its tolerability figure does not travel.
- [Amycretin: What the Published Trials Actually Show | GLP Loss](https://glploss.com/research/amycretin-what-we-know): Amycretin, now zenagamtide: the phase 1 and phase 2 results with their confidence intervals, what the trials were actually designed to measure, where it stands in development, and what is unknown.
- [ATTAIN-1 Explained: 11.2% at 72 Weeks, and the Columns That Reverse | GLP Loss](https://glploss.com/research/attain-1-trial-explained): ATTAIN-1 gave orforglipron 36 mg an 11.2% weight change at 72 weeks against 2.1% on placebo. Which estimand that figure belongs to, and where tolerability stops tracking dose.
- [ATTAIN-2 Explained: An Oral GLP-1 in Type 2 Diabetes | GLP Loss](https://glploss.com/research/attain-2-trial-explained): ATTAIN-2 tested once-daily orforglipron in 1,613 adults with obesity and type 2 diabetes. The weight difference was 7.1 points, the glucose result larger, and three columns did not move.
- [Bacteriostatic Water and Reconstitution: What the Diluent Label Actually Says](https://glploss.com/research/bacteriostatic-water-and-reconstitution): Bacteriostatic versus sterile water for injection: benzyl alcohol, the neonatal warning, what the diluent label permits, and pharmacy mixing versus mixing it yourself.
- [CagriSema vs Tirzepatide: What Cannot Be Compared | GLP Loss](https://glploss.com/research/cagrisema-vs-tirzepatide): CagriSema against tirzepatide: the four phase 3 trials, why their designs block a clean comparison, and the network meta-analyses that rank them in opposite orders.
- [CagriSema: What the REDEFINE Trials Actually Found | GLP Loss](https://glploss.com/research/cagrisema-what-we-know): The REDEFINE and REIMAGINE readouts for CagriSema, what the combination added over semaglutide alone, and why it is not approved or available.
- [Compounded vs Brand-Name GLP-1: What Actually Differs | GLP Loss](https://glploss.com/research/compounded-vs-brand-glp1): What separates compounded semaglutide and tirzepatide from Wegovy, Ozempic and Zepbound — regulatory status, what the trials studied, and why the prices differ so much.
- [What Testing Found in Counterfeit GLP-1s | GLP Loss](https://glploss.com/research/counterfeit-and-grey-market-glp1): Published assays of semaglutide bought from illegal online sellers: content above label, purity under 15%, endotoxin in every sample, and vials that held insulin.
- [ESSENCE Explained: An Interim Read on a Trial That Ends in 2029 | GLP Loss](https://glploss.com/research/essence-trial-explained): ESSENCE resolved steatohepatitis in 62.9% against 34.3% on placebo at week 72. Why that is an interim histology result in 800 of 1,197 patients, not an outcome.
- [FLOW Explained: The Semaglutide Kidney Outcomes Trial | GLP Loss](https://glploss.com/research/flow-trial-explained): FLOW's primary composite, hazard ratio, hierarchical secondaries and SGLT2-inhibitor subgroup — and what the kidney evidence does and does not show without diabetes.
- [What Rules Govern How a GLP-1 Can Be Advertised | GLP Loss](https://glploss.com/research/glp1-advertising-rules): How prescription drug advertising is regulated, why almost none of it reaches a compounded GLP-1, what the FTC still requires, and which claims are not permitted.
- [GLP-1 After Bariatric Surgery: The Regain Evidence | GLP Loss](https://glploss.com/research/glp1-after-bariatric-surgery): Using a GLP-1 after sleeve or bypass: one randomized trial of 70 adults, pooled cohorts near 9% at twelve months, and the tirzepatide trial still unreported.
- [GLP-1 Abdominal Pain: One Reaction, Six Definitions | GLP Loss](https://glploss.com/research/glp1-and-abdominal-pain): What the six GLP-1 labels actually count under abdominal pain, why the dose curve is flat, how the molecule ranking flips between instruments, and the compounded dosing-error signal.
- [GLP-1s and Acid Reducers: What a PPI Does to the Tablet | GLP Loss](https://glploss.com/research/glp1-and-acid-reducers): Omeprazole raised oral semaglutide exposure to a ratio of 1.13, and HbA1c fell 1.56% with a PPI versus 1.08% without. The label's water and timing rules matter more than pH.
- [GLP-1s and ADHD Stimulants: What Nobody Has Measured | GLP Loss](https://glploss.com/research/glp1-and-adhd-stimulants): Zero studies pair a GLP-1 with an ADHD stimulant. Stimulant labels give +3 to 6 bpm and +2 to 4 mmHg; semaglutide gives +1 to 4 bpm and -5.1 mmHg systolic.
- [GLP-1s for Adolescents: What STEP TEENS Actually Showed | GLP Loss](https://glploss.com/research/glp1-and-adolescents): Semaglutide is approved from 12. What STEP TEENS measured, why a teen BMI percentage is not an adult weight percentage, and what growth data does not exist.
- [GLP-1 and Alcohol: What the Craving Evidence Shows | GLP Loss](https://glploss.com/research/glp1-and-alcohol): Semaglutide and alcohol: what the randomized trials measured, what the craving reports rest on, and what the labels do and do not say about drinking.
- [GLP-1 for Alcohol Use Disorder: How Strong Is the Case? | GLP Loss](https://glploss.com/research/glp1-and-alcohol-use-disorder): GLP-1 drugs and alcohol use disorder: the brain receptor evidence, why registry hazard ratios shift with the comparator, and how trials compare to naltrexone.
- [EVOKE and EVOKE+: The Alzheimer's Trials Read Out | GLP Loss](https://glploss.com/research/glp1-and-alzheimers-evoke): The evoke and evoke+ trials of oral semaglutide in early Alzheimer's disease: the mechanism argument, the design, the published results with their confidence intervals, and what is still open.
- [Amylin Analogs: What the Class Has Actually Shown | GLP Loss](https://glploss.com/research/glp1-and-amylin-analogs): What amylin does, what pramlintide, cagrilintide, eloralintide and petrelintide have shown alone, the tolerability data behind the class's reputation, and where it stands.
- [Anti-Drug Antibodies and GLP-1 Drugs: What the Labels Report and What They Never Tested](https://glploss.com/research/glp1-and-anti-drug-antibodies): Anti-drug antibody rates on every approved GLP-1 label, how few neutralize, what the labels say was never assessed, and the impurity route that links this to compounding.
- [GLP-1s and Antidepressants: What the Subgroup Data Show | GLP Loss](https://glploss.com/research/glp1-and-antidepressants): Semaglutide weight loss by antidepressant use at baseline, how little weight antidepressants themselves move, and what the depression trials actually measured.
- [GLP-1 Aspiration Risk: A Surrogate That Quadrupled, an Outcome That Did Not](https://glploss.com/research/glp1-and-aspiration-risk): What the endoscopy, ultrasound and cohort evidence measures on GLP-1 aspiration risk: retention odds of 4.54, aspiration pneumonia at 0.96, and why both are true.
- [GLP-1s, Asthma and COPD: What the Observational Data Shows | GLP Loss](https://glploss.com/research/glp1-and-asthma-and-copd): Pooled across 62,678 adults, GLP-1s beat sulfonylureas on airway exacerbations (IRR 0.52), tied with SGLT-2 inhibitors, and lost to metformin (IRR 1.24).
- [GLP-1s and Athletes: Lean Mass, Strength and the Doping Rules | GLP Loss](https://glploss.com/research/glp1-and-athletes): What DXA shows about fat-free mass on GLP-1s, whether resistance training changes the ratio, what happens to strength, and the WADA status of semaglutide.
- [GLP-1 Bloating: The Weakest Signal on the Whole GI Table | GLP Loss](https://glploss.com/research/glp1-and-bloating): What the GLP-1 labels record for abdominal distension, why its pooled relative risk is the lowest of any GI symptom, how big the gastric emptying delay really is, and the obstruction boundary.
- [GLP-1 and Blood Pressure: Real, Rented, and Not Dose-Dependent | GLP Loss](https://glploss.com/research/glp1-and-blood-pressure): How much GLP-1 drugs lower blood pressure, why the ambulatory numbers beat the office ones, the deprescribing hidden inside the trials, and who the effect is worth something to.
- [GLP-1 Body Composition: What the DXA and MRI Substudies Found | GLP Loss](https://glploss.com/research/glp1-and-body-composition): What the DXA, MRI and cardiac MR substudies measured about fat, lean mass and each fat depot on GLP-1 drugs, and why both muscle-loss headlines are wrong.
- [GLP-1 and Bone Density: What the DXA Scans Found | GLP Loss](https://glploss.com/research/glp1-and-bone-density): GLP-1 and bone: the four-arm randomized DXA trial, the resistance-training trial that failed in older adults, the protein data, and the fracture hazard ratio that reverses.
- [GLP-1 Ileus and Bowel Obstruction: What the Labels Say | GLP Loss](https://glploss.com/research/glp1-and-bowel-obstruction): Where ileus and bowel obstruction sit on the GLP-1 labels, what the 10/2025 warning actually added, why the pharmacovigilance signal has no denominator, and who carries the anatomy.
- [GLP-1s and Breastfeeding: What Has Actually Been Measured | GLP Loss](https://glploss.com/research/glp1-and-breastfeeding): GLP-1s and lactation: what the four labels say, the 19 women in the two human milk studies, and the infant outcomes nobody has measured.
- [GLP-1s and Caffeine: What Has Actually Been Studied | GLP Loss](https://glploss.com/research/glp1-and-caffeine): Caffeine and GLP-1 drugs have never been studied together. What is known about caffeine and gastric emptying, and why the popular advice has no trial behind it.
- [GLP-1s After Cancer: What the Warning Covers, and What Nobody Measured](https://glploss.com/research/glp1-and-cancer-survivors): GLP-1s and a cancer history: what the boxed warning actually excludes, why the reassuring cohorts do not apply to survivors, and the one survivor study that exists.
- [Ozempic and Weed: What Is Known About GLP-1s and Cannabis | GLP Loss](https://glploss.com/research/glp1-and-cannabis): Is it safe to use weed on Ozempic or Zepbound? What the labels say, how THC and GLP-1s both slow the stomach, CHS vs GLP-1 vomiting, and the cannabis use disorder data.
- [GLP-1 and Cholesterol: Which Column Actually Moves | GLP Loss](https://glploss.com/research/glp1-and-cholesterol): What GLP-1 drugs do to LDL, triglycerides, non-HDL and apolipoprotein levels, where the LDL effect disappears, and how much of the lipid change is independent of weight loss.
- [GLP-1 Constipation: The Mechanism Does Not Survive Measurement | GLP Loss](https://glploss.com/research/glp1-and-constipation): Why GLP-1 constipation is probably an intake effect, not a motility one — plus what the fiber and hydration trials actually found, with their costs.
- [Treating GLP-1 Constipation: What Has and Has Not Been Tested | GLP Loss](https://glploss.com/research/glp1-and-constipation-management): What the laxative, fiber and fluid evidence actually shows for GLP-1 constipation, how the guideline ranks each agent, and the trials that were never run in this population.
- [GLP-1, Dehydration and Kidney Injury: Reading the Warning | GLP Loss](https://glploss.com/research/glp1-and-dehydration): The GLP-1 volume-depletion warning, the trial rates behind it, why acute kidney injury concentrates in the titration weeks, and why three instruments rank the molecules differently.
- [GLP-1s and Dental Work: What the Sedation Warning Covers | GLP Loss](https://glploss.com/research/glp1-and-dental-work): Dental procedures on a GLP-1: what the anesthesia warning actually covers, which sedation depths have been studied, dry mouth and erosion, and what to tell a dentist.
- [GLP-1s and Dialysis: What the Labels Claim and What Was Tested | GLP Loss](https://glploss.com/research/glp1-and-dialysis): GLP-1s in end-stage kidney disease: what each label says, the 8-patient PK basis, the single randomized dialysis trial, and the 42-study Cochrane count.
- [GLP-1 Diarrhea: Rates, Molecules and the Dose Reversal | GLP Loss](https://glploss.com/research/glp1-and-diarrhea): Trial diarrhea rates on semaglutide and tirzepatide against placebo, how the risk ranks by molecule, why dose moves it opposite to constipation, and when it settles.
- [GLP-1s and Water Pills: The Dose That Stops Being Right | GLP Loss](https://glploss.com/research/glp1-and-diuretics): No GLP-1 label names a diuretic. Hypotension ran 2.2% on antihypertensives against 1.2% without, and loop diuretic dose fell 17% over 52 weeks on semaglutide.
- [GLP-1 Dizziness: Dehydration, Blood Pressure or Low Sugar | GLP Loss](https://glploss.com/research/glp1-and-dizziness): Trial dizziness rates on semaglutide and tirzepatide, and how to separate dehydration, the real blood-pressure reduction, hypoglycemia and reduced intake as causes.
- [GLP-1 Dry Mouth: A Ten-Fold Ratio on a 1% Count | GLP Loss](https://glploss.com/research/glp1-and-dry-mouth): What the GLP-1 labels record for dry mouth, why the ratio and the count disagree, the dehydration and receptor pathways, and how thin the dental evidence is.
- [GLP-1 and Difficulty Swallowing: What the Labels Actually Say | GLP Loss](https://glploss.com/research/glp1-and-dysphagia): Dysphagia appears on every GLP-1 label only as a thyroid-tumor symptom, never as a GI reaction. What manometry, a randomized trial and the surgical cohorts found.
- [GLP-1s and a History of an Eating Disorder: What Is Known | GLP Loss](https://glploss.com/research/glp1-and-eating-disorder-history): GLP-1s and eating disorder history: binge-eating scores fall in 12 small studies, adverse-event reports run the other way, and anorexia has zero trials.
- [Eating Out on a GLP-1: What the Timing Data Actually Show | GLP Loss](https://glploss.com/research/glp1-and-eating-out): Restaurants, holidays and big meals on a GLP-1: how the gastric emptying effect fades, when symptom episodes actually cluster, and why nausea is not the mechanism.
- [GLP-1s and Seizure Medications: Nobody Has Drawn a Level | GLP Loss](https://glploss.com/research/glp1-and-epilepsy-medications): Six GLP-1 labels name no antiseizure drug and no trial has measured one's blood level. What has been measured is seizure recurrence: hazard ratio 0.82 across 8,688 matched pairs.
- [GLP-1 and Exercise: What the Training Trials Measured | GLP Loss](https://glploss.com/research/glp1-and-exercise): One trial randomized exercise alongside a GLP-1. Training doubled the drop in body-fat percentage, and former exercisers held a 10% loss at far higher odds.
- [Semaglutide and the Eyes: NAION and Retinopathy in Absolute Numbers | GLP Loss](https://glploss.com/research/glp1-and-eye-health): What the published evidence shows on semaglutide, NAION and diabetic retinopathy worsening — absolute risks, the subgroup where the effect reverses, and what FOCUS has not settled.
- [“Ozempic Face”: What Imaging Measured, and What It Cannot Separate | GLP Loss](https://glploss.com/research/glp1-and-facial-volume-loss): Imaging found 7% of midfacial volume lost per 10 kg on a GLP-1, mostly superficial fat. Why no study has separated the drug from the weight loss.
- [GLP-1 Fatigue: A Signal That Sorts by Agent, Not by Class | GLP Loss](https://glploss.com/research/glp1-and-fatigue): Do GLP-1 drugs cause fatigue? What 262 randomized trials recorded, why the trial and reporting instruments both under-read it, and which causes hold up.
- [GLP-1 and Fatty Liver: What the MASH Biopsies Showed | GLP Loss](https://glploss.com/research/glp1-and-fatty-liver): Semaglutide in MASH: 62.9% resolution against 34.3% on placebo in ESSENCE, a failed fibrosis endpoint in phase 2, and a cirrhosis trial that went the other way.
- [GLP-1s, Fertility and IVF: The Washout and the Missing Endpoint | GLP Loss](https://glploss.com/research/glp1-and-fertility-and-ivf): GLP-1s before conception: the asymmetric washout instructions, the preconception weight-loss trials that raised pregnancies without raising live births, and what nobody has measured.
- [GLP-1s and Air Travel: Cabin Pressure, Dry Ice and a Thin Evidence Base](https://glploss.com/research/glp1-and-flying): What is actually published about flying with a GLP-1: the certified cabin altitude, the pressure studies done on insulin pumps, the dry ice rule, and half-lives.
- [Food Noise on GLP-1 Drugs: What Has Been Measured | GLP Loss](https://glploss.com/research/glp1-and-food-noise): Where the term food noise came from, the two instruments built to measure it, what the craving trials recorded, and what separates the phenomenon from the pitch.
- [GLP-1s and Gastroparesis: The Signal and Its Denominator | GLP Loss](https://glploss.com/research/glp1-and-gastroparesis): GLP-1 gastroparesis risk with the denominators attached: the 3.67 hazard ratio, the 313,342-pair cohort, the randomized null, and what the labels really say.
- [GLP-1s and Reflux: The Risk Reverses on Half-Life | GLP Loss](https://glploss.com/research/glp1-and-gerd): Do GLP-1 drugs cause acid reflux? The cohort risk sits almost entirely with short-acting agents, while the weight loss resolves heartburn in most people.
- [GLP-1s and Gout: Urate Fell, Attacks Did Not | GLP Loss](https://glploss.com/research/glp1-and-gout): GLP-1s and gout: urate fell 0.95 mg/dL in SURMOUNT-1, but across 22 randomized trials and 173,498 patients gout events did not move at all.
- [Do GLP-1s Cause Hair Loss? The Trials, and the Surgery Comparison | GLP Loss](https://glploss.com/research/glp1-and-hair-loss): Alopecia was 5.4% versus 0.9% on placebo in the tirzepatide trials. Why the risk tracks weight lost rather than dose, and what the bariatric literature shows.
- [GLP-1 Headache: How Much Is the Drug, and How Much Is Placebo | GLP Loss](https://glploss.com/research/glp1-and-headache): What the GLP-1 labels record for headache next to their placebo arms, why no meta-analysis has pooled it, the dehydration and hypoglycemia routes, and the trials treating headache with this class.
- [GLP-1 and Heart Failure: The HFpEF and HFrEF Split | GLP Loss](https://glploss.com/research/glp1-and-heart-failure): STEP-HFpEF, SUMMIT, FIGHT and LIVE read together: large symptom and walk-distance gains in HFpEF, and two negative randomized trials in HFrEF.
- [GLP-1 and Heart Rate: How Many Beats, and Whether It Matters | GLP Loss](https://glploss.com/research/glp1-and-heart-rate): Labeled resting heart-rate increases on semaglutide, tirzepatide and liraglutide, the 20 bpm tail behind the mean, palpitation reports, and why only two of six labels warn about it.
- [GLP-1 and Hiccups: On One Label, With No Number Attached | GLP Loss](https://glploss.com/research/glp1-and-hiccups): Hiccups appear on one of seven GLP-1 labels with no incidence figure, on 205 semaglutide and 107 tirzepatide adverse-event reports, and in no published study.
- [GLP-1s and HIV: A Small Literature at Half the Dose | GLP Loss](https://glploss.com/research/glp1-and-hiv): GLP-1s alongside antiretroviral therapy: what the one randomized trial measured, why every dose studied was 1 mg, and what the interaction evidence does and does not cover.
- [How Much Water on a GLP-1: The Advice With No Number Behind It | GLP Loss](https://glploss.com/research/glp1-and-hydration): What the GLP-1 labels actually say about drinking, where the daily water figures came from, and what a randomized trial of drinking more found about kidney decline.
- [GLP-1 Hypoglycemia: The Population Nobody Counted | GLP Loss](https://glploss.com/research/glp1-and-hypoglycemia): What the GLP-1 labels record for hypoglycemia at each glucose threshold, why the monotherapy rate does not separate from placebo, and the population the obesity trials did not measure.
- [GLP-1s and IBD: What the Crohn's and Colitis Data Show | GLP Loss](https://glploss.com/research/glp1-and-ibd): GLP-1s with Crohn's or ulcerative colitis: no randomized trials, 16,242 patients in matched cohorts, and a target trial emulation that found no benefit at all.
- [GLP-1 and IBS: Why the Drug Name Matters | GLP Loss](https://glploss.com/research/glp1-and-ibs): An experimental GLP-1 analog reduced IBS pain in a small trial. That does not establish that Ozempic, Wegovy, or Zepbound treats irritable bowel syndrome.
- [GLP-1s and Tacrolimus: The Interaction That Should Matter Most | GLP Loss](https://glploss.com/research/glp1-and-immunosuppressants): Tacrolimus troughs shifted -0.2 to +0.2 ng/mL on a GLP-1. Graft loss fell 49% in recipients with diabetes at transplant, and not at all in post-transplant diabetes.
- [GLP-1s and Insulin: The Dose Reduction the Label Asks For | GLP Loss](https://glploss.com/research/glp1-and-insulin): Semaglutide's label shows 3.8% hypoglycemia alone and 29.8% on basal insulin, while pooled trials against insulin intensification show RR 0.46. What the label instructs, and what it omits.
- [GLP-1 and Kidney Disease: What the FLOW Trial Found | GLP Loss](https://glploss.com/research/glp1-and-kidney-disease): FLOW cut major kidney disease events by 24% in diabetic kidney disease. The entry criteria, the eGFR slope, the class meta-analysis, and what the dose was.
- [GLP-1 and Kidney Stones: What the Urine Studies Show | GLP Loss](https://glploss.com/research/glp1-and-kidney-stones): Small studies do not show a clear worsening of stone-forming urine chemistry, but that is different from proving semaglutide or tirzepatide prevents kidney stones.
- [GLP-1s and Levothyroxine: The Interaction on the Label | GLP Loss](https://glploss.com/research/glp1-and-levothyroxine): Levothyroxine exposure rose 33% with oral semaglutide, one Medicare emulation found more atrial fibrillation, and TSH testing did not change after GLP-1 starts.
- [GLP-1 and Libido: What No Trial Measured | GLP Loss](https://glploss.com/research/glp1-and-libido): The GLP-1 labels record no sexual side effect at all. A claims study found erectile dysfunction risk rising 4.5-fold in non-diabetic men — and a diabetic cohort found the opposite.
- [GLP-1s and Lithium: The Interaction No Label Mentions | GLP Loss](https://glploss.com/research/glp1-and-lithium): Lithium is toxic above 1.5 mEq/L and therapeutic at 0.8 to 1.2. Four case reports describe levels climbing after a GLP-1 started — one from 0.9 to 1.7 in four days.
- [GLP-1s and Liver Impairment: What the Labels Do and Do Not Say | GLP Loss](https://glploss.com/research/glp1-and-liver-disease): GLP-1s in cirrhosis and liver impairment: what the labels say, the 44-person pharmacokinetic basis for 'no dose adjustment', and the cohorts that disagree.
- [GLP-1s and Low Testosterone: Which Number Actually Moves | GLP Loss](https://glploss.com/research/glp1-and-low-testosterone): Total testosterone rose across 680 men on GLP-1 drugs, but free testosterone was inconsistent — and in men starting above 320 ng/dL it fell from 74.7 to 64.2 pg/mL.
- [GLP-1 and Lupus: Small Studies, Important Limits | GLP Loss](https://glploss.com/research/glp1-and-lupus): An 18-person lupus cohort and a separate suspected drug-induced lupus case answer different questions. Neither establishes that GLP-1 medicines treat lupus or quantifies a causal risk.
- [GLP-1 and Menopause: What the Transition Actually Changes | GLP Loss](https://glploss.com/research/glp1-and-menopause): SWAN found no acceleration in weight gain at the menopause transition — but fat gain doubled and lean mass fell. What that means before starting a GLP-1.
- [GLP-1s and Men: What the Trials Actually Measured | GLP Loss](https://glploss.com/research/glp1-and-mens-health): Men lost 6.8% of body weight against 10.9% in women across 19,906 patients — but MACE fell 14% in men and 18% in women, with a sex interaction p-value of 0.47.
- [GLP-1s and Menstrual Changes: What Was Actually Measured | GLP Loss](https://glploss.com/research/glp1-and-menstrual-changes): A term-by-term read of six GLP-1 labels finds no menstrual adverse reaction, an animal cycle effect at every dose, and FAERS signals that run opposite by molecule.
- [GLP-1s and Mental Health: Reading the Suicidality Evidence | GLP Loss](https://glploss.com/research/glp1-and-mental-health): What regulators reviewed after the 2023 suicidality reports, what the cohort studies and pooled trials found in absolute numbers, and what is still unknown.
- [GLP-1s and Metabolic Syndrome: A Cluster That Moves Unevenly | GLP Loss](https://glploss.com/research/glp1-and-metabolic-syndrome): GLP-1s and metabolic syndrome: how unevenly the five criteria respond, why the composite predicts worse than its parts, and why no label mentions it.
- [GLP-1 and Micronutrients: Inferred Almost Everywhere, Measured Almost Nowhere](https://glploss.com/research/glp1-and-micronutrient-gaps): What is actually measured about micronutrients on GLP-1 drugs: 0.12% reported malnutrition against 2.90% on bloodwork, a 28-person intake study, and the NHANES baseline.
- [GLP-1s and Migraine: The Pressure Theory and Its Limits | GLP Loss](https://glploss.com/research/glp1-and-migraine): No randomized trial of GLP-1s in migraine exists. A 189,392-person Danish series found triptan use fell 7% — 8% in women, and not significantly in men.
- [GLP-1 Access on TRICARE and at the VA: The Rule and the Override | GLP Loss](https://glploss.com/research/glp1-and-military-and-tricare): What TRICARE's statute and regulation actually say about GLP-1 coverage, what the VA national formulary file carries, and what the military claims data show.
- [GLP-1s and Multiple Sclerosis: One 28-Person Trial | GLP Loss](https://glploss.com/research/glp1-and-multiple-sclerosis): GLP-1s and multiple sclerosis: one 28-person randomized trial that missed both primary endpoints, 109 patients in two clinics, and no evidence of benefit.
- [GLP-1 Muscle Cramps: A Word on No Label | GLP Loss](https://glploss.com/research/glp1-and-muscle-cramps): What the GLP-1 labels record for muscle cramps, why the depletion model reverses where it was tested, and what the randomized evidence says about magnesium.
- [GLP-1 and Muscle Loss: What Has Actually Been Measured | GLP Loss](https://glploss.com/research/glp1-and-muscle-loss): GLP-1 body composition, honestly: muscle measures fell 1.41 kg against 6.02 kg of fat across 38 reports — under a fifth of the total weight that came off.
- [GLP-1s and NSAIDs: The Kidney Risk Nobody Writes Down | GLP Loss](https://glploss.com/research/glp1-and-nsaids): Zero published NSAID interaction studies with a GLP-1. Both labels describe the same kidney event from opposite sides, and the triple-whammy AKI odds ratio is 2.01.
- [GLP-1s After 65: What the Age-Specific Evidence Shows | GLP Loss](https://glploss.com/research/glp1-and-older-adults): The GLP-1 evidence in adults over 65 is five studies and 1,229 people. What the age subgroups actually show on weight, fractures, lean mass and polypharmacy.
- [GLP-1s and the Pill: Why Only One Label Says Use Backup | GLP Loss](https://glploss.com/research/glp1-and-oral-contraceptives): Tirzepatide's label instructs four weeks of backup contraception; semaglutide's never mentions it. Exenatide cut peak levels 46% — but only when the pill came after the shot.
- [GLP-1s and Oral Medications: What the Interaction Trials Found | GLP Loss](https://glploss.com/research/glp1-and-oral-medications): What the GLP-1 drug interaction trials measured for warfarin, digoxin, metformin, statins and contraceptives, which changes are real, and which are only modeled.
- [GLP-1s and Osteoarthritis: What the Knee Trials Measured | GLP Loss](https://glploss.com/research/glp1-and-osteoarthritis): GLP-1s and knee osteoarthritis: STEP 9's 41.7-point WOMAC drop against 27.5 on placebo, and a liraglutide trial that found no pain benefit at all.
- [GLP-1s and PCOS: What the Evidence Actually Shows | GLP Loss](https://glploss.com/research/glp1-and-pcos): GLP-1s in PCOS: 11 randomized trials, a pooled BMI change of -1.38 kg/m², and an androgen benefit that vanishes once the comparator is metformin.
- [Why a Pharmacy Needs a License in Your State | GLP Loss](https://glploss.com/research/glp1-and-pharmacy-licensure-by-state): What a nonresident pharmacy license is, what seven states require before an out-of-state pharmacy may ship in, why that limits who serves which states, and how to verify it.
- [GLP-1s and Prediabetes: What Reversion Actually Buys | GLP Loss](https://glploss.com/research/glp1-and-prediabetes): GLP-1s and prediabetes: 81% reverted to normoglycemia against 14% on placebo, odds ratio 19.8 — and what the natural history and off-treatment data do to that number.
- [GLP-1s and Psoriasis: What the One Large Trial Measured | GLP Loss](https://glploss.com/research/glp1-and-psoriasis): GLP-1s and psoriasis: the phase 3b tirzepatide trial's real skin number, the 76-person randomized record before it, and a cohort that found more new psoriasis.
- [GLP-1s and Rheumatoid Arthritis: No Trial, One Chart Review | GLP Loss](https://glploss.com/research/glp1-and-rheumatoid-arthritis): GLP-1s and rheumatoid arthritis: zero randomized trials, zero registered studies, one 215-patient chart review, and an unmeasured methotrexate question.
- [GLP-1 and Set Point Theory: Moved, or Just Held Down? | GLP Loss](https://glploss.com/research/glp1-and-set-point-theory): What weight regain after stopping implies about a body-weight set point, the metabolic adaptation evidence behind it, and whether these drugs move it or hold it.
- [GLP-1 and SGLT2 Inhibitors: When Two Diabetes Drugs Help | GLP Loss](https://glploss.com/research/glp1-and-sglt2-inhibitors): Can GLP-1 drugs be taken with Jardiance or Farxiga? Read the combination-trial evidence, kidney-outcome limits, and safety questions for type 2 diabetes.
- [GLP-1 Sharps Disposal: What the Rules Actually Require | GLP Loss](https://glploss.com/research/glp1-and-sharps-disposal): Fifty-two used needles a year: what FDA guidance, the four approved GLP-1 labels, and California and Massachusetts law each require for sharps disposal.
- [GLP-1s and Shift Work: Mostly Extrapolation, and Which Parts Are Not | GLP Loss](https://glploss.com/research/glp1-and-shift-workers): GLP-1s on a night or rotating shift: what weekly dosing does and does not care about, what the circadian evidence actually measured, and how much of this is extrapolation.
- [GLP-1 Rash and Hypersensitivity: What the Labels Record | GLP Loss](https://glploss.com/research/glp1-and-skin-reactions): Labeled rash, urticaria and hypersensitivity rates for tirzepatide, semaglutide and liraglutide, the anaphylaxis contraindication language, and what a compounded blend adds to an allergy question.
- [GLP-1 and Sleep: What the Research Actually Recorded | GLP Loss](https://glploss.com/research/glp1-and-sleep): Sleep quality, insomnia and vivid dreams on a GLP-1: the 78-patient cohort, the 20-minute randomized effect, and the sleep finding that predicts weight regain.
- [GLP-1 and Sleep Apnea: What SURMOUNT-OSA Measured | GLP Loss](https://glploss.com/research/glp1-and-sleep-apnea): SURMOUNT-OSA lowered the apnea-hypopnea index by 20 to 24 events per hour against placebo. What that endpoint measures, and what CPAP trials showed it cannot.
- [GLP-1 and Sleep Quality: The Unnumbered Endpoint | GLP Loss](https://glploss.com/research/glp1-and-sleep-quality): Tirzepatide ranks second of all sleep apnea treatments for the breathing count and is absent from those shown to reduce daytime sleepiness. What the label quantified, and what it left blank.
- [GLP-1 and Smell Changes: The Test Moves the Other Way | GLP Loss](https://glploss.com/research/glp1-and-smell-changes): What the GLP-1 labels record about smell, the FAERS olfactory signal at ROR 2.44, and why every prospective olfactory measurement under these drugs moved the other way.
- [GLP-1 and Smoking: What the Trials Found | GLP Loss](https://glploss.com/research/glp1-and-smoking-cessation): GLP-1 drugs and smoking: the abstinence results with their intervals, why the large real-world hazard ratios appear within 30 days, and how much randomized evidence exists.
- [GLP-1s and Statins: Three Studies, Three Directions | GLP Loss](https://glploss.com/research/glp1-and-statins): Four GLP-1 interaction studies put statin exposure at 0.79, 1.06 and 1.41. Weight loss cuts triglycerides 15.6% but LDL only 2.2% — and +0.4% in the diabetes trial.
- [GLP-1s and Sulfonylureas: The Interaction That Reaches the Hospital | GLP Loss](https://glploss.com/research/glp1-and-sulfonylureas): With a sulfonylurea, hypoglycemia ran 10.3% versus 2.1% in the same tirzepatide trial and did not track the injection dose. What the labels instruct, and who has to act on it.
- [GLP-1s Before Surgery: The Fasting Guidance, Revised | GLP Loss](https://glploss.com/research/glp1-and-surgery-anesthesia): Holding semaglutide or tirzepatide before anesthesia: the 2023 ASA rule, the 2024 multisociety revision, what the labels say, and the gastric-content evidence.
- [GLP-1 and Taste Changes: A Reward Shift, Not a Taste Loss | GLP Loss](https://glploss.com/research/glp1-and-taste-changes): What the GLP-1 trials recorded for dysgeusia, why the randomized taste test found perception sharpened rather than dulled, and what shifted instead: preference and reward.
- [GLP-1 and Thyroid Cancer: The Warning and the Data | GLP Loss](https://glploss.com/research/glp1-and-thyroid-cancer-risk): Semaglutide thyroid cancer risk: the rodent C-cell finding behind the boxed warning, why it is species-specific, and what human cohorts have found since.
- [Flying With a GLP-1: TSA Rules and Dose-Day Math | GLP Loss](https://glploss.com/research/glp1-and-travel): Flying with semaglutide or tirzepatide: what TSA actually allows at the checkpoint, how far the dose day can move on each label, and what a failed cooler costs.
- [GLP-1s and Type 1 Diabetes: The Off-Label Evidence | GLP Loss](https://glploss.com/research/glp1-and-type-1-diabetes): Off-label GLP-1 use in type 1 diabetes: what the adjunct trials found, why the ketosis signal sits on the best-performing dose, and what the labels actually say.
- [Vaccines and GLP-1s: A Census of What Nobody Has Measured | GLP Loss](https://glploss.com/research/glp1-and-vaccines): Whether there is any evidence on vaccines and GLP-1 drugs: the label census, the literature census with controls, and what the obesity vaccine data actually show.
- [GLP-1 Vomiting: Rates by Dose, and a Ratio That Inverts | GLP Loss](https://glploss.com/research/glp1-and-vomiting): Trial vomiting rates on semaglutide, tirzepatide and liraglutide by dose, why the pooled ratios rank the molecules in reverse, the dehydration and kidney pathway, and when it warrants stopping.
- [GLP-1s and Warfarin: How Thin the Evidence Really Is | GLP Loss](https://glploss.com/research/glp1-and-warfarin): Four PK studies found no warfarin exposure change and INR ratios of 0.94 and 0.88. One cohort of 1,021 patients found time in range fell 2.1 points. Two case reports disagree.
- [GLP-1 Denials and Appeals: The Levels, Rates and Deadlines | GLP Loss](https://glploss.com/research/glp1-appeals-and-denials): The appeal levels for employer, marketplace and Medicare drug denials, the deadlines that bind, and the published overturn rates by level rather than in aggregate.
- [Beyond-Use Dates on Compounded GLP-1: What the Date on the Vial Means](https://glploss.com/research/glp1-beyond-use-dating): What sets a beyond-use date on a compounded GLP-1 vial: FDA's 9, 28 and 42-day defaults, the 1,000-unit ceiling, and why puncturing never adds 28 fresh days.
- [Biosimilar or Generic? Where a GLP-1 Peptide Sits | GLP Loss](https://glploss.com/research/glp1-biosimilars-vs-generics): Why GLP-1 peptides are copied as generics rather than biosimilars, what the 40-amino-acid rule does, and what the pathway does and does not mean for price and substitution.
- [Cancellation and Refund Terms: What Cancel Anytime Means | GLP Loss](https://glploss.com/research/glp1-cancellation-and-refund-terms): A September 2026 snapshot of 257 reviews: cancellation notices, prepaid commitments and refund stages, with current examples for comparing a selected plan.
- [When a GLP-1 Arrives Warm: What the Labels Permit | GLP Loss](https://glploss.com/research/glp1-cold-chain-and-warm-shipments): What the Wegovy, Ozempic, Zepbound and Mounjaro labels permit for storage outside a refrigerator, and what a buyer can and cannot conclude from a warm package.
- [What a GLP-1 Costs Once You Reach a Maintenance Dose | GLP Loss](https://glploss.com/research/glp1-cost-at-maintenance): Maintenance is a dose range, not a dose. What each approved rung costs on a published GLP-1 ladder, and what a seller's cheaper maintenance tier actually caps.
- [What a Year on a GLP-1 Actually Costs | GLP Loss](https://glploss.com/research/glp1-cost-over-a-year): Compare GLP-1 billing periods, memberships and opening rates across a year. Annualized costs differ from cash payments due on actual billing dates.
- [GLP-1 Cost Per Pound: The Comparison Nobody Runs | GLP Loss](https://glploss.com/research/glp1-cost-per-pound): Trial mean losses divided by real GLP-1 prices: about $80 a pound for semaglutide, $82 for tirzepatide, $115 at the lowest dose and $212 a year after stopping.
- [GLP-1 Dose Timing: What the Labels Actually Permit | GLP Loss](https://glploss.com/research/glp1-dose-timing): What day and time to inject a GLP-1: the labeled rules on changing the day, the 48- and 72-hour minimum intervals, and where meal timing does and does not matter.
- [Employer GLP-1 Coverage: What the Surveys Actually Show | GLP Loss](https://glploss.com/research/glp1-employer-coverage): KFF's 2025 survey of 1,862 employers on GLP-1 coverage: who covers it by firm size, who intends to add it, and what a carve-out or step-therapy rule changes.
- [GLP-1 for Diabetes vs Weight Loss: Two Approvals, One Molecule | GLP Loss](https://glploss.com/research/glp1-for-diabetes-vs-weight-loss): One molecule, two approvals: what the diabetes trials measured, what the obesity trials measured, and why the same dose loses less weight in type 2 diabetes.
- [GLP-1 for Women and Men: What Actually Differs | GLP Loss](https://glploss.com/research/glp1-for-women-and-men): A 248-patient cohort found no outcome difference by sex, while a 19,906-patient pooled estimate finds men lose less — and tirzepatide cuts peak oral-contraceptive levels by up to 66%.
- [GLP-1 Gallstones and Pancreatitis: The Absolute Rates | GLP Loss](https://glploss.com/research/glp1-gallbladder-and-pancreatitis): Gallbladder and pancreatitis risk on semaglutide and tirzepatide: what the trials and meta-analyses found, and what the absolute event rates actually are.
- [GLP-1 Generics: The Dates, and What Liraglutide Did | GLP Loss](https://glploss.com/research/glp1-generics-timeline): When GLP-1 patents and exclusivities actually lapse, and what generic entry did to liraglutide's acquisition cost month by month in the federal pricing file.
- [GLP-1 Half-Life and Steady State: What the Labels Say | GLP Loss](https://glploss.com/research/glp1-half-life-and-steady-state): Labeled half-lives for semaglutide, tirzepatide, dulaglutide, liraglutide and exenatide, the steady-state arithmetic on top of them, and the three places the labels disagree with it.
- [GLP-1 and the Heart: What the Outcome Trials Found | GLP Loss](https://glploss.com/research/glp1-heart-benefits): SELECT, SUSTAIN-6, LEADER, STEP-HFpEF and FLOW, read plainly: what semaglutide did to cardiovascular events, who was enrolled, and the absolute figures.
- [How GLP-1 Sellers Advertise a Price | GLP Loss](https://glploss.com/research/glp1-how-sellers-advertise-a-price): From-prices, first-month figures, four-week cycles sold as months, struck-through anchors, prepay rungs and prices that render nowhere — counted across 257 GLP-1 sellers.
- [How to Read a Certificate of Analysis for a Compounded GLP-1 | GLP Loss](https://glploss.com/research/glp1-how-to-read-a-certificate-of-analysis): What a certificate of analysis states, what the statute actually requires one for, and how often a GLP-1 seller publishes one — counted across 286 written-up sellers.
- [Can You Use an HSA or FSA for a GLP-1? | GLP Loss](https://glploss.com/research/glp1-hsa-and-fsa): What IRS Publication 502 and 969 actually require for a GLP-1 to be HSA or FSA eligible, where a letter of medical necessity fits, and the 2026 account limits.
- [GLP-1 Injection-Site Reactions: What the Trials Recorded | GLP Loss](https://glploss.com/research/glp1-injection-site-reactions): Trial injection-site reaction rates for semaglutide and tirzepatide, why antibody status predicts them better than technique, and what compounded B12 and glycine blends add.
- [GLP-1 Injection Technique: What the Labels Specify, and What They Leave Open](https://glploss.com/research/glp1-injection-technique): Injection site, angle, pinching, speed and rotation for a weekly GLP-1, read from the four current FDA labels and the randomized injection literature.
- [GLP-1 Insurance vs Cash Pay: How the Two Routes Differ | GLP Loss](https://glploss.com/research/glp1-insurance-vs-cash-pay): Why compounded GLP-1s sit outside insurance, what coverage generally looks like for the approved products, and the four questions that settle it for your plan.
- [GLP-1 Blood Tests: What to Ask Before and During Treatment | GLP Loss](https://glploss.com/research/glp1-lab-tests): Which blood tests are needed for GLP-1 treatment? Understand label-based monitoring, symptom-led testing, and what to ask about a telehealth lab package.
- [Not Losing Weight on Tirzepatide? What Late Response Means | GLP Loss](https://glploss.com/research/glp1-late-responders): Not losing weight on tirzepatide? Learn what late-response research shows, why week twelve may be early, and which questions belong in a clinical follow-up.
- [GLP-1 Long Term: How Far the Evidence Actually Runs | GLP Loss](https://glploss.com/research/glp1-long-term-what-we-know): GLP-1 long-term evidence: 208 weeks in SELECT, 176 in SURMOUNT-1, 104 in STEP 5 and 160 in SCALE — what held, what narrowed, and what has never been studied.
- [Medicare and Medicaid GLP-1 Coverage: The Rule and Its Exceptions | GLP Loss](https://glploss.com/research/glp1-medicare-and-medicaid): The Part D weight-loss exclusion read from the statute and the rulemaking record: what it bars, the indications it does not, and how the 13-state Medicaid map moved.
- [GLP-1 Microdosing: What the Dose Evidence Covers | GLP Loss](https://glploss.com/research/glp1-microdosing): What a dose-ranging trial found at 0.05 to 0.4 mg daily, why no published trial covers a reduced weekly protocol, and how to read a microdose price honestly.
- [Missed a GLP-1 Dose: What the Four Labels Say | GLP Loss](https://glploss.com/research/glp1-missed-dose): Missed semaglutide or tirzepatide dose: the catch-up window on each FDA label, why Ozempic and Wegovy differ, and why no label tells anyone to double up.
- [GLP-1 Nausea: When It Starts, Peaks and Settles | GLP Loss](https://glploss.com/research/glp1-nausea-how-long): How long does GLP-1 nausea last? It clusters around each dose step, not the whole course. What STEP 4 and SELECT recorded about timing and who stopped.
- [Needle Fear and GLP-1 Injections: What the Evidence Measures | GLP Loss](https://glploss.com/research/glp1-needle-anxiety): Measured prevalence of needle fear, the randomized evidence on reducing it, and what the oral-versus-injection persistence data actually shows for GLP-1 buyers.
- [GLP-1 Needles: Length, Gauge and What Actually Reaches Muscle | GLP Loss](https://glploss.com/research/glp1-needles-and-syringes): Needle length and gauge for a weekly GLP-1 injection, read from ultrasound anatomy studies, two randomized needle-length trials and the current FDA labels.
- [GLP-1 Patches: What They Contain and Why None Is a Drug | GLP Loss](https://glploss.com/research/glp1-patches): GLP-1 patches contain no semaglutide or tirzepatide. What is in them, why the drug cannot cross skin, what microneedle research shows, and what is approved.
- [Semaglutide Patents: What Expires, Where, and When | GLP Loss](https://glploss.com/research/glp1-patent-expiry-and-generics): When semaglutide patent protection lapses by market, what already launched in Canada and India, and what that does and does not mean for US prices.
- [Importing a GLP-1 From Abroad: What the Rules Actually Say | GLP Loss](https://glploss.com/research/glp1-personal-importation): What FDA's personal importation policy says, what the statute prohibits, how import alerts override the discretion, and what the counterfeit seizure record shows.
- [When the Pharmacy Changes: Why Two Compounded Vials Are Not Interchangeable](https://glploss.com/research/glp1-pharmacy-substitution): What changes when a telehealth platform switches compounding pharmacies, what therapeutic equivalence means, and what a buyer can and cannot verify.
- [GLP-1s, Pregnancy and the Birth Control Interaction | GLP Loss](https://glploss.com/research/glp1-pregnancy-and-contraception): GLP-1s in pregnancy: what the labels require, what 49,395 exposed pregnancies showed, and the four-week contraceptive rule that is specific to tirzepatide.
- [Prepay Rungs and Membership Fees: What They Add | GLP Loss](https://glploss.com/research/glp1-prepay-plans-and-membership-fees): Compare prepay tiers, four-week cycles and separate memberships across 1,108 recorded GLP-1 prices, with current-price normalization separated from historical repricing.
- [GLP-1 Prior Authorization: What It Requires and What It Costs | GLP Loss](https://glploss.com/research/glp1-prior-authorization): What a GLP-1 prior authorization asks for, the decision clocks that actually bind, why the 2026 federal reform excludes drugs, and what approval is worth.
- [Eating on a GLP-1: Protein, Appetite and the Trial Diets | GLP Loss](https://glploss.com/research/glp1-protein-and-diet): Semaglutide cut test-meal intake by 35%. What the trial diets prescribed, why adequacy gets hard on a smaller plate, and where the protein figures come from.
- [GLP-1 Savings Cards: Who Actually Qualifies, and What It Costs | GLP Loss](https://glploss.com/research/glp1-savings-cards-and-copay-programs): NovoCare and LillyDirect terms read at the source: who the $25 card excludes, the real self-pay prices, the caps and expiry dates, and the 28-day month.
- [The GLP-1 Shortage List, and What Ended It | GLP Loss](https://glploss.com/research/glp1-shortage-list-and-what-ended-it): When semaglutide and tirzepatide were added to and removed from the FDA shortage list, what the wind-down deadlines were, and what compounders may lawfully do now.
- [GLP-1 Side Effects: What the Trials Recorded | GLP Loss](https://glploss.com/research/glp1-side-effects): Semaglutide and tirzepatide side effects from the pivotal trials: what was reported, how often people discontinued, and why the dose is escalated slowly.
- [State Boards, Complaints, and What You Can Look Up | GLP Loss](https://glploss.com/research/glp1-state-boards-and-complaints): How a state board of pharmacy or medicine handles a complaint, what becomes public and when, how long it stays visible, and the four things a buyer can verify themselves.
- [State Telehealth Rules and Your GLP-1 Subscription | GLP Loss](https://glploss.com/research/glp1-state-telehealth-rules): How state prescribing and pharmacy law shapes a cash GLP-1 subscription: licensure where the patient sits, what counts as a valid examination, nonresident pharmacy permits, and the federal clause that defers to all three.
- [GLP-1 Storage: What Each Label Actually Allows | GLP Loss](https://glploss.com/research/glp1-storage-and-handling): Semaglutide and tirzepatide storage limits read from the current FDA labels: fridge range, room-temperature days by product, light, travel and compounded vials.
- [A Power Outage and a GLP-1 in the Refrigerator: What the Labels Allow | GLP Loss](https://glploss.com/research/glp1-storage-when-power-fails): What the current FDA labels permit after a refrigerator failure, how the unrefrigerated allowance works, and why a compounded vial has no answer at all.
- [GLP-1 Sulfur Burps: A Top Signal With No Study Behind It | GLP Loss](https://glploss.com/research/glp1-sulfur-burps): What is actually known about sulfur burps on GLP-1 drugs: the eructation reporting signal, the belching reflex, the hydrogen sulfide evidence, and the gap.
- [GLP-1 Supplements and Berberine: What the Trials Show | GLP Loss](https://glploss.com/research/glp1-supplements-and-berberine): Berberine pools to −0.88 kg across 23 trials; semaglutide's STEP 1 gap was −12.7 kg. What the RCTs show for GLP-1 supplements, plus berberine drug interactions.
- [Switching From a Brand GLP-1 to a Compounded One | GLP Loss](https://glploss.com/research/glp1-switching-brand-to-compounded): Moving from an approved GLP-1 pen to a compounded vial: what changes about the concentration and units, where the documented errors happen, and what no buyer can verify.
- [Switching From Semaglutide to Tirzepatide: The Evidence | GLP Loss](https://glploss.com/research/glp1-switching-semaglutide-to-tirzepatide): Switching from semaglutide to tirzepatide: what the switch trials measured, why the label still starts everyone at 2.5 mg, and the 2.9% nobody quotes.
- [Tapering Off a GLP-1: What Has Actually Been Tested | GLP Loss](https://glploss.com/research/glp1-tapering-off): Does tapering off a GLP-1 work? The one randomized dose-reduction trial, what the regain data show, and the four questions about tapering nobody has measured.
- [The Consent and Terms You Sign for a GLP-1 | GLP Loss](https://glploss.com/research/glp1-telehealth-consent-what-you-sign): What a GLP-1 telehealth buyer agrees to before a prescription: the consent to treat, the terms of service, the billing authorization and the data documents — and how to read each one.
- [GLP-1 Telehealth: Seven Patterns Worth Checking | GLP Loss](https://glploss.com/research/glp1-telehealth-red-flags): Seven ways a GLP-1 telehealth price can mean less than it looks like, what to ask about each, and why none of them is evidence about a particular seller.
- [Cash Telehealth or a Clinic Visit: What Each Price Buys | GLP Loss](https://glploss.com/research/glp1-telehealth-vs-in-person-cost): Compare cash GLP-1 subscriptions with clinic visits and pharmacy fills. Published prices cover different product groups and cannot isolate the cost of a visit.
- [GLP-1 Titration: The Dose Climb and What It Costs | GLP Loss](https://glploss.com/research/glp1-titration-schedule): GLP-1 escalation takes 16 weeks on semaglutide and 20 on tirzepatide. Why a seller's dose-pricing policy costs more across a year than its opening price does.
- [Vial or Pen: What the Error Data and the Labels Say | GLP Loss](https://glploss.com/research/glp1-vial-vs-pen): A multi-dose GLP-1 vial against a prefilled pen: FAERS reporting odds, poison-center cases, the preservatives only multi-dose labels carry, and what it costs.
- [GLP-1 vs Bariatric Surgery: What Each Route Has Been Shown to Do | GLP Loss](https://glploss.com/research/glp1-vs-bariatric-surgery): Surgery vs a GLP-1: 28.6% against 11.3% at twelve months, remission of 23–70% against 0%, and two meta-analyses on mortality that the largest cohort contradicts.
- [GLP-1 vs GIP: What the Second Receptor Really Adds | GLP Loss](https://glploss.com/research/glp1-vs-gip-what-the-second-receptor-does): What GIP agonism contributes to tirzepatide, why an antagonist antibody also causes weight loss, and what the head-to-head trials cannot attribute to the second receptor.
- [GLP-1 vs Liraglutide: What the Older Molecule Still Has | GLP Loss](https://glploss.com/research/glp1-vs-liraglutide): Daily liraglutide against the weekly GLP-1 agents: the head-to-head trials, the three-year data, the LEADER result, the children's trial, and the generic supply.
- [GLP-1 vs Metformin: The Cheap Drug's Fifteen-Year Record | GLP Loss](https://glploss.com/research/glp1-vs-metformin): Metformin against a GLP-1 on weight, glycemia and price: 28.5% reached 5% at one year, 6.2% held at fifteen, and what the only randomized comparison actually asked.
- [GLP-1 vs Contrave: The Trial That Was Stopped Before It Could Answer | GLP Loss](https://glploss.com/research/glp1-vs-naltrexone-bupropion): Contrave against a GLP-1: the COR trial effect sizes, a 50% completion rate, the LIGHT cardiovascular trial's two interim looks, and the contraindications that rule people out.
- [GLP-1 vs Orlistat: The 37% That Applied to a Fifth of the Trial | GLP Loss](https://glploss.com/research/glp1-vs-orlistat): Orlistat against a GLP-1: the pooled 2.9 kg effect, the four-year XENDOS result and its subgroup limit, the side-effect rates from the label, and the price gap.
- [GLP-1 vs Phentermine: The Drug That Ranked First, Then Last | GLP Loss](https://glploss.com/research/glp1-vs-phentermine): Phentermine and Qsymia against a GLP-1: the 56- and 108-week trial results, the label's duration limit, the cost case, and the ranking that inverted in two years.
- [Weekly vs Daily GLP-1 Injections: What the Interval Actually Buys | GLP Loss](https://glploss.com/research/glp1-weekly-vs-daily-dosing): Weekly semaglutide and tirzepatide against daily liraglutide: the STEP 8 head-to-head, the adherence evidence with its confounders, half-lives from the labels, and what daily dosing still offers.
- [The GLP-1 Weight Loss Plateau: When Loss Slows and Stops | GLP Loss](https://glploss.com/research/glp1-weight-loss-plateau): Loss on semaglutide ran about 65 weeks, then held for three more years. What a higher dose bought in the one trial that tested it, and what it really cost.
- [What a 503B Outsourcing Facility Actually Is | GLP Loss](https://glploss.com/research/glp1-what-a-503b-outsourcing-facility-is): How a 503B outsourcing facility registers, what it pays, what it must report, and why its clinical-need list of bulk drug substances has only five entries.
- [What a Compounding Pharmacy Charges | GLP Loss](https://glploss.com/research/glp1-what-a-compounding-pharmacy-charges): Published cost-of-manufacture estimates for semaglutide and liraglutide, what they do and do not bound, and why the pharmacy-to-telehealth price is not public.
- [What a GLP-1 Telehealth Intake Actually Asks | GLP Loss](https://glploss.com/research/glp1-what-a-telehealth-intake-asks): What an online GLP-1 intake can screen, what it cannot, and why a video visit closes none of the gap — with lab policy counted across 286 written-up sellers.
- [What Happens to Your Data in Cash-Pay GLP-1 Telehealth | GLP Loss](https://glploss.com/research/glp1-what-happens-to-your-data): Why HIPAA may not cover a cash-pay GLP-1 telehealth seller, what the FTC breach rule and state health-data laws reach instead, and what a buyer can check first.
- [What Your Money Buys in a Monthly GLP-1 Price | GLP Loss](https://glploss.com/research/glp1-what-your-money-buys): Consultation, supplies, shipping, labs, messaging and dose changes — how often each is actually specified inside a monthly GLP-1 price, counted across 257 sellers.
- [GLP-1 Doses and Acute Illness: What the Evidence Actually Covers | GLP Loss](https://glploss.com/research/glp1-when-you-are-sick): Vomiting or a stomach bug on a GLP-1: what the Wegovy and Zepbound labels warn about dehydration, why sick-day rules were written for other drugs, and the gaps.
- [Year Two on a GLP-1 Costs More Than Year One | GLP Loss](https://glploss.com/research/glp1-year-one-vs-year-two-cost): Why year two on a GLP-1 bills higher than year one: dose ladders, the weeks spent climbing, and what real-world titration data does to the projection.
- [Who Actually Regulates a Compounding Pharmacy | GLP Loss](https://glploss.com/research/how-a-compounding-pharmacy-is-regulated): Who inspects a 503A compounding pharmacy, what FDA's residual authority covers, how many states enforce the USP chapters, and what accreditation does not mean.
- [How GLP-1 Drugs Work, and What the Mechanism Leaves Out | GLP Loss](https://glploss.com/research/how-glp1-drugs-work): The incretin effect, where appetite signaling happens, what gastric emptying really contributes, and the four things this mechanism cannot predict.
- [How Much Weight People Lost on Semaglutide in the Trials | GLP Loss](https://glploss.com/research/how-much-weight-loss-semaglutide): Semaglutide 2.4 mg produced a mean −14.9% over 68 weeks in STEP 1, against −2.4% on placebo. What the average hides, and what happened in STEP 4 on withdrawal.
- [How Much Weight Tirzepatide Took Off in the SURMOUNT Trials | GLP Loss](https://glploss.com/research/how-much-weight-loss-tirzepatide): Tirzepatide weight results by dose: −15.0%, −19.5% and −20.9% at 72 weeks in SURMOUNT-1, what held at three years, and how the figures fall with diabetes.
- [How to Get a GLP-1 Prescription for Weight Loss | GLP Loss](https://glploss.com/research/how-to-get-a-glp1-prescription): How to get prescribed a GLP-1 like Ozempic or Wegovy for weight loss: who qualifies under the labels, three routes to a prescriber, insurance vs cash prices.
- [How to Vet the Pharmacy Behind a Compounded GLP-1 | GLP Loss](https://glploss.com/research/how-to-vet-a-compounding-pharmacy): 503A pharmacy or 503B outsourcing facility: who inspects each, what registration does and does not certify, and the questions that make a supplier checkable.
- [OASIS 1 Explained: 15% From a Tablet Nobody Sells | GLP Loss](https://glploss.com/research/oasis-1-trial-explained): OASIS 1 tested oral semaglutide 50 mg in 667 adults over 68 weeks: 15.1% weight loss against 2.4% on placebo. Which estimand that came from, and why 50 mg is not sold.
- [OASIS 4 Explained: The 307-Person Trial Behind the Semaglutide Tablet | GLP Loss](https://glploss.com/research/oasis-4-trial-explained): OASIS 4 randomized 307 adults to oral semaglutide 25 mg or placebo. Its weight result, its two estimands, its one-point discontinuation gap, and the diabetes figures that were simulated.
- [Once-Monthly GLP-1 Candidates: What the Trials Show | GLP Loss](https://glploss.com/research/once-monthly-glp1-candidates): Once-monthly GLP-1 dosing: the phase 2 results with intervals and confidence intervals, what the registered phase 3 enrollment reveals, and what monthly would not change.
- [Oral Tirzepatide: What Exists, and What Is Being Sold | GLP Loss](https://glploss.com/research/oral-tirzepatide-what-we-know): There is no approved oral tirzepatide and no registered trial of one. What the absorption data actually shows, and what 43 sellers are advertising instead.
- [Oral vs Injectable GLP-1: What the Tablet Trials Show | GLP Loss](https://glploss.com/research/oral-vs-injectable-glp1): Oral semaglutide reached −15.1% and −13.6% in the OASIS trials against −14.9% for the weekly injection. Three separate trials, and no compounded tablet in any.
- [Orforglipron: What the Phase 3 Trials Show, and Its Status | GLP Loss](https://glploss.com/research/orforglipron-what-we-know): Orforglipron's phase 3 results, why an oral non-peptide needs no absorption enhancer or fasting window, and what its April 2026 FDA approval covers.
- [PIONEER 4 Explained: The Semaglutide Tablet Against an Injection | GLP Loss](https://glploss.com/research/pioneer-4-trial-explained): PIONEER 4 compared oral semaglutide with subcutaneous liraglutide and placebo over 52 weeks. The superiority test on the primary endpoint failed, and the patient-reported columns did not separate.
- [PIONEER 6 Explained: The Composite That Missed and the Deaths That Halved](https://glploss.com/research/pioneer-6-trial-explained): PIONEER 6 reported a hazard ratio of 0.79 for cardiovascular events on oral semaglutide, and did not reach superiority. What its components show, and what it never tested.
- [REDEFINE 1 Explained: 3,417 People, and 302 in the Arm That Mattered | GLP Loss](https://glploss.com/research/redefine-1-trial-explained): REDEFINE 1's 21:3:3:7 allocation, its coprimary endpoints, the −20.4% result, and the pooled findings on what cagrilintide added to semaglutide — including the ones that run the other way.
- [REDEFINE 2 Explained: What CagriSema Does in Type 2 Diabetes | GLP Loss](https://glploss.com/research/redefine-2-trial-explained): REDEFINE 2 gave cagrilintide-semaglutide to 904 adults with type 2 diabetes for 68 weeks. The placebo-adjusted weight difference was 10.4 points. What that number is next to.
- [Retatrutide vs Tirzepatide: A Comparison That Reverses | GLP Loss](https://glploss.com/research/retatrutide-vs-tirzepatide-what-we-know): A phase 2 compound against an approved one: the trial numbers, the four reasons they are not commensurable, the one matched pair of trials, and what remains unknown.
- [Retatrutide: What the Trials Show, and Why You Cannot Buy It | GLP Loss](https://glploss.com/research/retatrutide-what-we-know): Retatrutide's phase 2 and phase 3 results with doses and sample sizes, why it is not FDA-approved, and what assays found inside vials sold as research peptides.
- [Rybelsus vs Injectable Semaglutide: One Molecule, Two Routes | GLP Loss](https://glploss.com/research/rybelsus-vs-injectable-semaglutide): Oral and injectable semaglutide compared on bioavailability, exposure, dosing rules and trial results — including why the milligram figures do not convert.
- [SCALE Obesity and Prediabetes Explained: Liraglutide 3.0 mg | GLP Loss](https://glploss.com/research/scale-obesity-trial-explained): SCALE Obesity and Prediabetes tested liraglutide 3.0 mg in 3,731 adults. The difference was 5.6 kg at 56 weeks, and 9.6% of the drug arm left for adverse events.
- [SELECT Explained: The Semaglutide Cardiovascular Trial | GLP Loss](https://glploss.com/research/select-trial-explained): SELECT's primary endpoint, hazard ratio, absolute risk difference, number needed to treat and weight change — plus what the adiposity analyses actually showed.
- [Semaglutide Doses Explained: 0.25 mg to 2.4 mg | GLP Loss](https://glploss.com/research/semaglutide-doses-explained): The semaglutide dose ladder rung by rung: 0.25, 0.5, 1, 1.7 and 2.4 mg, what each step is actually for, what the trials tested, and which rungs sellers skip.
- [Semaglutide Sodium and Acetate: Why the Salt Forms Fail the Compounding Test](https://glploss.com/research/semaglutide-salt-forms): Semaglutide sodium and acetate versus the base peptide: the three statutory conditions for a compounding bulk substance, and why a salt clears none of them.
- [SOUL Explained: Oral Semaglutide and Heart Outcomes | GLP Loss](https://glploss.com/research/soul-trial-explained): What SOUL measured: a hazard ratio of 0.86 in 9,650 adults, a heart-failure subgroup that reverses, and why a compounded oral tablet inherits none of it.
- [STEP 1 Explained: The Trial Behind the 14.9% Figure | GLP Loss](https://glploss.com/research/step-1-trial-explained): How STEP 1 was built: the 2:1 randomization with no run-in, the treatment policy estimand, what ended treatment, and what the year-long extension found.
- [STEP 2 Explained: Why the Same Dose Gave 9.6% | GLP Loss](https://glploss.com/research/step-2-trial-explained): STEP 2 gave −9.6% on the same semaglutide dose that gave −14.9% in STEP 1. What explains the gap, what does not, and why cross-trial comparison fails.
- [STEP 3 Explained: Semaglutide Plus Thirty Counseling Visits | GLP Loss](https://glploss.com/research/step-3-trial-explained): STEP 3 reached −16.0% against −5.7% on placebo, a difference of 10.3 points. Why the most intensively supported semaglutide trial measured the smallest drug effect.
- [STEP 4 Explained: What Happens When Semaglutide Stops | GLP Loss](https://glploss.com/research/step-4-trial-explained): STEP 4's run-in, randomization, primary endpoint and confirmatory secondaries — plus the year-off extension data and what the trial never tested.
- [STEP 5 Explained: What the Second Year of Semaglutide Bought | GLP Loss](https://glploss.com/research/step-5-trial-explained): STEP 5's two-year result, read as a curve: −15.2% against −2.6%, a plateau after week 60, craving control that persisted, and serious adverse events that ran the other way.
- [STEP 6 Explained: Semaglutide in Japan and South Korea | GLP Loss](https://glploss.com/research/step-6-trial-explained): STEP 6 tested semaglutide 2.4 mg and 1.7 mg in 401 adults in Japan and South Korea. The treatment difference was 11.06 points, and visceral fat on CT fell 41%.
- [STEP 7 Explained: A 44-Week Clock and a Busy Placebo Arm | GLP Loss](https://glploss.com/research/step-7-trial-explained): STEP 7 tested semaglutide 2.4 mg in 375 adults over 44 weeks. The treatment difference was 8.47 points, and its placebo arm lost 3.6% in two thirds of the usual time.
- [STEP 8 Explained: The Head-to-Head, and the Column Nobody Tested | GLP Loss](https://glploss.com/research/step-8-trial-explained): STEP 8 reached −15.8% against −6.4%, a 9.4-point difference. Why its famous 13.5%-versus-27.6% discontinuation figure carries no confidence interval.
- [STEP 9 Explained: Semaglutide and the Arthritic Knee | GLP Loss](https://glploss.com/research/step-9-trial-explained): STEP 9 tested semaglutide 2.4 mg in 407 people with obesity and knee osteoarthritis. The pain difference was 14.14 points with a wide interval, and one column did not separate at all.
- [STEP-HFpEF Explained: The Symptom Score That Ignored the Weight | GLP Loss](https://glploss.com/research/step-hfpef-trial-explained): STEP-HFpEF's design, its two primary endpoints, the safety inversion in its placebo arm, and why the symptom benefit did not track the weight difference between its two trials.
- [STEP TEENS Explained: The 16% Is a BMI Change, Not a Weight Change | GLP Loss](https://glploss.com/research/step-teens-trial-explained): STEP TEENS tested semaglutide 2.4 mg in 201 adolescents. The preregistered primary was BMI, not weight: down 16.2% against 0.1%, a difference of 16.75 points.
- [STRIDE Explained: 13% Further, and It Was Not the Weight | GLP Loss](https://glploss.com/research/stride-trial-explained): STRIDE tested semaglutide 1.0 mg in 792 adults with peripheral artery disease and type 2 diabetes. The real treatment ratio, the subgroups, and what the trial never measured.
- [SUMMIT Explained: The HFpEF Trial Powered on Events | GLP Loss](https://glploss.com/research/summit-trial-explained): SUMMIT's design, eligibility funnel and results: a composite primary endpoint at HR 0.62, mortality pointing the other way, and how it differs from the STEP-HFpEF trials.
- [SURMOUNT-1 Explained: Inside the Tirzepatide Trial | GLP Loss](https://glploss.com/research/surmount-1-trial-explained): SURMOUNT-1's design, estimand and substudies: body composition, time to plateau, blood pressure mediation, and what changed in the 17 weeks off treatment.
- [SURMOUNT-2 Explained: Tirzepatide With Type 2 Diabetes | GLP Loss](https://glploss.com/research/surmount-2-trial-explained): SURMOUNT-2's design, cohort and result: −14.7% against −3.2% on placebo, the rescue-therapy estimand, and the week-8 split that separates −21.2% from −11.2%.
- [SURMOUNT-3 Explained: The Lifestyle Lead-In Was a Filter | GLP Loss](https://glploss.com/research/surmount-3-trial-explained): SURMOUNT-3 randomized only lifestyle responders: 579 of 806. Tirzepatide added −18.4% against +2.5% on placebo, and cost more in tolerability than SURMOUNT-1.
- [SURMOUNT-4 Explained: Stopping Tirzepatide, Measured | GLP Loss](https://glploss.com/research/surmount-4-trial-explained): SURMOUNT-4's lead-in, randomization, primary and key secondary endpoints — and why the +14.0% regain cannot be read as tirzepatide rebounding harder than semaglutide.
- [SURMOUNT-5 Explained: The Head-to-Head, Read Properly | GLP Loss](https://glploss.com/research/surmount-5-trial-explained): SURMOUNT-5's design and limits: the open label, the 6.5-point primary difference and its interval, the modeled maximum-dose analysis, and the tolerability table that came out even.
- [SURMOUNT-MAINTAIN: Can a Lower Tirzepatide Dose Hold Weight Loss?](https://glploss.com/research/surmount-maintain): SURMOUNT-MAINTAIN compared lower-dose tirzepatide, continued higher doses, and withdrawal. Read the weight results, rescue rule, and maintenance limits.
- [SURMOUNT-MMO Explained: The Tirzepatide Outcome Trial That Has Not Reported](https://glploss.com/research/surmount-mmo-trial-explained): SURMOUNT-MMO's design, enrollment and timeline read from the registry — and what stands in for it: a noninferiority result against dulaglutide that missed superiority at P = 0.09.
- [SURMOUNT-OSA Explained: Two Trials, Split by the Machine | GLP Loss](https://glploss.com/research/surmount-osa-trial-explained): How SURMOUNT-OSA was built: 469 participants across two trials, a composite disease-control endpoint reached by 42.2% and 50.2%, and a completion rate that ran backwards.
- [SURPASS-1 Explained: Tirzepatide Alone Against Placebo | GLP Loss](https://glploss.com/research/surpass-1-trial-explained): SURPASS-1 tested tirzepatide monotherapy against placebo in 478 people over 40 weeks. The weight column climbs with dose and two of the glucose columns do not.
- [SURPASS-2 Explained: The Head-to-Head Ran at the Diabetes Dose | GLP Loss](https://glploss.com/research/surpass-2-trial-explained): SURPASS-2 compared tirzepatide with semaglutide 1 mg in 1,879 adults with type 2 diabetes over 40 weeks. The real effect sizes, the two sets of figures, and the safety columns.
- [SURPASS-3 Explained: Tirzepatide Against Titrated Insulin | GLP Loss](https://glploss.com/research/surpass-3-trial-explained): SURPASS-3 compared tirzepatide with treat-to-target insulin degludec over 52 weeks in 1,444 people. What the trial's MRI and glucose-monitoring substudies found, including the muscle column.
- [SURPASS-4 Explained: A Glucose Trial People Quote for Its Heart Column](https://glploss.com/research/surpass-4-trial-explained): SURPASS-4 compared tirzepatide with titrated insulin glargine over up to 104 weeks. The 0.74 cardiovascular hazard ratio came from 109 events in a safety analysis, not an outcome trial.
- [SURPASS-5 Explained: Tirzepatide Added to Insulin | GLP Loss](https://glploss.com/research/surpass-5-trial-explained): SURPASS-5 tested tirzepatide on top of insulin glargine in 475 people. The control arm escalated its insulin by 75%, and the hypoglycemia column reverses the monotherapy result.
- [SURPASS-AP-Combo Explained: Tirzepatide Against Insulin | GLP Loss](https://glploss.com/research/surpass-ap-combo-trial-explained): SURPASS-AP-Combo's design and limits: a non-inferiority primary on two doses only, an active insulin comparator, the odds ratio built on a zero-event arm, and who it enrolled.
- [SURPASS-CVOT Explained: Noninferior to a Drug That Already Works | GLP Loss](https://glploss.com/research/surpass-cvot-trial-explained): SURPASS-CVOT compared tirzepatide with dulaglutide 1.5 mg in 13,299 patients. The cardiovascular composite returned 0.92 and missed superiority. What that comparator choice means.
- [Survodutide and Mazdutide: What the Trials Show So Far | GLP Loss](https://glploss.com/research/survodutide-and-mazdutide-what-we-know): Survodutide and mazdutide: phase 2 and phase 3 weight results with confidence intervals, where each stands in development, the Chinese approval, and what is still unknown.
- [SUSTAIN-6 Explained: A Safety Trial Read as a Benefit Trial | GLP Loss](https://glploss.com/research/sustain-6-trial-explained): SUSTAIN-6 reported a hazard ratio of 0.74 in 3,297 adults with type 2 diabetes. Why that came from a post hoc superiority test, and what the composite hides.
- [Tirzepatide Doses Explained: 2.5 mg to 15 mg | GLP Loss](https://glploss.com/research/tirzepatide-doses-explained): The tirzepatide dose ladder rung by rung: 2.5, 5, 7.5, 10, 12.5 and 15 mg, which are approved maintenance doses, which are only steps, and what trials tested.
- [Tirzepatide vs Semaglutide: What the Trials Actually Measured | GLP Loss](https://glploss.com/research/tirzepatide-vs-semaglutide): Tirzepatide vs semaglutide: SURMOUNT-5 found 20.2% versus 13.7% mean weight loss at 72 weeks. Compare the evidence, limitations, risks, and cost.
- [Wegovy Pill: Dosing, Results, Side Effects and Cost | GLP Loss](https://glploss.com/research/wegovy-pill): Is Wegovy a pill or an injection? Both. The once-daily tablet: FDA approval, the 1.5 mg to 25 mg ladder, the fasting rules, OASIS 4 results, side effects and the $149–$299 cash price.
- [Wegovy vs Ozempic: Same Molecule, Two Different Labels | GLP Loss](https://glploss.com/research/wegovy-vs-ozempic): Wegovy and Ozempic are both semaglutide. What the two labels approve, where the dose ladders split, what 7.2 mg adds, and why the same molecule has three prices.
- [What a LegitScript Certification Actually Proves | GLP Loss](https://glploss.com/research/what-a-legitscript-certification-proves): What LegitScript certification covers and excludes, how to check a seal in the public lookup instead of trusting a badge, and why a missing seal proves nothing.
- [What an FDA Warning Letter Actually Means | GLP Loss](https://glploss.com/research/what-a-warning-letter-means): What an FDA warning letter is, how an untitled letter differs, what a close-out letter does and does not establish, and how to search the database for a seller yourself.
- [What Happens When You Stop Taking a GLP-1 | GLP Loss](https://glploss.com/research/what-happens-when-you-stop): Randomized withdrawal trials show substantial weight regain after stopping semaglutide or tirzepatide — and what that means for the monthly price you are comparing.
- [What Is Actually in a Compounded GLP-1 Vial | GLP Loss](https://glploss.com/research/what-is-in-a-compounded-vial): Inside a compounded GLP-1 vial: base versus salt forms of semaglutide, concentration versus dose, added preservatives, and the untested B12 and NAD blends.
- [What “Not FDA-Approved” Actually Means | GLP Loss](https://glploss.com/research/what-not-fda-approved-actually-means): FDA approval turns on five findings in section 505(d). A compounded GLP-1 is exempt from all of them — which is not the same as unsafe, untested or illegal.
- [Who Should Not Take a GLP-1: The Short List and the Long One | GLP Loss](https://glploss.com/research/who-should-not-take-glp1): Semaglutide and tirzepatide contraindications: the two things the labels rule out absolutely, and the longer list of conditions that need a prescriber first.
- [Why GLP-1 Prices Range From Under $80 to Over $600 | GLP Loss](https://glploss.com/research/why-glp1-prices-vary-so-much): What actually drives GLP-1 price variation: 503A versus 503B, vial versus pen, dose-indexed versus flat pricing, and memberships — read off 450 published prices.
- [Zepbound vs Mounjaro: Identical Doses, Different Approvals | GLP Loss](https://glploss.com/research/zepbound-vs-mounjaro): Zepbound and Mounjaro are the same tirzepatide at the same doses. What each label approves, what each trial measured, and why the CV claim is weaker than it reads.
- [Provider reviews: honest, evidence-first telehealth assessments | GLP Loss](https://glploss.com/reviews): Independent reviews of the GLP-1 sellers we track — compounded semaglutide and tirzepatide, injection and oral. What the plan term really is, what it costs month to month, and who each seller is for. No fabricated scores.
- [1st Optimal reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/1st-optimal): 1st Optimal combines coaching, laboratory-informed care and prescription assessment. Its membership price is not a GLP-1 drug quote, and conflicting public commitment terms need clarification before enrollment.
- [24hrDOC reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/24hrdoc): The big number on the semaglutide card is $135 and the crossed-out one is $159, but the footnote gives the discount for one month only.
- [9amHealth reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/9am-health): 9amHealth combines weight-management care with support for diabetes and heart health. The important purchase questions are which enrollment route applies, what the health plan covers and how ongoing medication access is maintained.
- [AbundRX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/abundrx): AbundRX prices its programs from $99 and $149 without ever saying what period either figure buys.
- [Actin reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/actin): Six prices sit on one product page: one-month, three-month and six-month rates for both semaglutide and tirzepatide.
- [AgelessRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/agelessrx): The compounded plan advertises $139 a month, and the same card states that the figure belongs to the four-month plan.
- [AHBARx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ahbarx): A single month of compounded semaglutide is $249, and the figure that looks like a monthly rate is the half-year plan divided down.
- [Alan Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/alan-meds): The standard compounded semaglutide injection is $315 a month, and the $158 printed beside it is that same month bought two at a time.
- [Alegro Health reviews (2026): Clinic and virtual weight management | GLP Loss](https://glploss.com/reviews/alegro-health): Alegro Health combines a McKinney clinic with virtual weight-management appointments. Its public pages describe GLP-1 prescribing, while the exact current medication and purchase terms require confirmation.
- [Alinwell reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/alinwell): The homepage prices semaglutide at $149 a month and tirzepatide at $199, while each program page replaces the figure with the words "Available by consultation".
- [Allara Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/allara-health): Allara combines medical and nutrition care, with a $149 monthly self-pay Complete Care membership. Prescriptions and laboratory work are additional costs.
- [Alloy reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/alloy): The $99 monthly Weight Care fee is already inside every figure here, so $169 for semaglutide is what the card is actually charged.
- [Alternate Health Club reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/alternate-health-club): $129 a month for compounded semaglutide and $169 for tirzepatide, held flat at every dose, with no membership fee behind either figure.
- [altRX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/altrx): Compounded semaglutide is $89 a month wherever it appears, while tirzepatide carries one price on the product page and a different one on the campaign pages.
- [Always Wellness and Recovery reviews (2026): compounded tirzepatide sellers](https://glploss.com/reviews/always-wellness-and-recovery): The pricing page sells three-month blocks charged up front, while the shop sells single monthly vials the pricing page never mentions, from $210 for semaglutide and $280 for tirzepatide.
- [AlyveRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/alyverx): Compounded semaglutide and tirzepatide are each priced twice, once as an injection and once as needle-free sublingual drops.
- [Amazon One Medical reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/amazon-one-medical): Amazon One Medical separates scheduled primary care from cash-pay, on-demand weight-loss visits. Neither the visit fee nor an eligible insurance copay establishes a complete medication budget.
- [Amble reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/amble): $179 semaglutide as a single figure; tirzepatide quoted as $289 rising to $329.
- [AMP Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/amp-health): Compounded semaglutide at $199 and tirzepatide at $309 both sit on top of a $79 monthly subscription, which makes the real monthly outlay $278 and $388.
- [AM Rx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/amrx): AM Rx combines online weight-management care, insurance coordination and compounded options. Its copay, membership fee and drug-inclusive bundles describe different purchases; compare the selected plan’s continuing cost.
- [Andrew Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/andrew-meds): Month to month, compounded semaglutide is $199 and tirzepatide is $299; the smaller figures on the same table belong to a twelve-month plan billed at the start.
- [Apex MD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/apex-md): $299 to $419 across four products, all month-to-month, with the semaglutide injection compounded alongside other ingredients.
- [AquaVita NextGen reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/aquavita-nextgen): A month of compounded semaglutide costs $215 at the checkout, while a live weight-loss page still frames the same injection as a first-month offer.
- [Arc-1 reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/arc-1): Compounded semaglutide and compounded tirzepatide are both priced at $199.99, and both figures climb once the prescribed dose does.
- [Ark Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ark-health): $169 for the semaglutide injection, $249 for the GIP injection and $125 for the oral, with nothing charged outside those figures — and two of the three pages never write the drug's name.
- [ARSYNL Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/arsynl-rx): A monthly price with the medication included and no membership fee, sold by a platform that names both pharmacies that may fill the prescription.
- [Ascend Medical reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ascend-medical): A starting package is priced, the first eight weeks are described, and what a month costs after that is never put in writing.
- [Ascend Vitality reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ascend-vitality): Each injectable leads with a three-month plan and offers the monthly rate underneath it, and the gap between the two is the whole story.
- [AskRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ask-rx): Nothing AskRx dispenses is compounded, and every medication price is quoted next to a flat monthly care fee rather than inside it.
- [Aspen reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/aspen-health): Aspen charges $179 a month whether you take semaglutide or tirzepatide, and the same figure at every dose.
- [Aspire Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/aspire-health): Every price carries its weekly milligram dose and the number of weeks the vial lasts, and a $49 monthly care fee sits outside all of them.
- [Auren Rx reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/auren-rx): $129 for semaglutide or tirzepatide — the same figure for both — on the subscribe rate, $149 without a commitment.
- [AVARA Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/avara-rx): Compounded semaglutide is $229 a month and tirzepatide $279, but a bar across the top of every page advertises plans from $179.
- [Avono Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/avono-health): Two separately priced programs, a flat rate inside each one, and a home page that sells the prepaid bundles the pricing page says do not exist.
- [AZ Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/az-health): Compounded semaglutide is $179 and compounded tirzepatide $199 — a $20 step between two molecules that usually sit much further apart.
- [Balanced Hormone Health reviews (2026): compounded semaglutide sellers](https://glploss.com/reviews/balanced-hormone-health): Prices are set by the total milligrams in the vial rather than by the month, so what a month costs depends entirely on the dose reached.
- [Bayan Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/bayan-health): The $99 figure buys a microdose protocol; the standard weekly semaglutide dose is a separate product at $129.
- [Believe Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/believe-health): Three GLP-1 programs, none of them priced on a public page, and a $129 monthly figure that appears only once the medical intake is finished.
- [Belle Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/belle-health): Every rung on Belle’s ladder carries a /month suffix, and the $109 one bills twelve months up front.
- [Better U Care reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/better-u-care): Compounded semaglutide is $298 a month and tirzepatide $397, each covering the medication and the provider consultation, and neither figure renders on a desktop screen.
- [BetterMe Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/betterme-rx): $199 is a sale price, and the countdown that makes it look temporary restarts every three days.
- [BeyondMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/beyondmd): Compounded semaglutide starts at $125 and compounded tirzepatide at $199, but the page titles and the older cost pages still name different numbers.
- [Big Easy Weight Loss reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/big-easy-weight-loss): Treatment is sold only in twelve-week packages: $495 for semaglutide, which works out to $165 a calendar month.
- [BiltRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/biltrx): Semaglutide is $81 a month and tirzepatide $129, and both sit on top of a membership and a consultation charged separately.
- [Bionomy Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/bionomy-health): Compounded semaglutide is $189 a month and tirzepatide $249, and a standing page names the two pharmacies that prepare them, city by city.
- [Bioverse reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/bioverse): $129 a month buys compounded semaglutide only on a six-month plan paid upfront in full, a condition the product page carrying that figure never mentions.
- [Blis MD reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/blis-md): $109 buys a vial the product page says delivers four weekly doses, and four-week fills land thirteen times a year.
- [Bliv reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/bliv): The headline offers a start as low as $58 a month; the semaglutide card further down the same page reads $116.
- [Bloom MD reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/bloommd): Liraglutide opens at $395 for a 3 mL vial, which is a month of the starting dose and about a week of the maintenance one.
- [BloomWell Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/bloomwell-rx): The domain serves a single Launching Soon page with a contact form, and prices no medication at all.
- [Blue Haven RX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/blue-haven-rx): Both product cards define a month as four weeks of medication, which turns the standing $179 and $259 rates into $194 and $281 across a year.
- [Blue Sky MD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/blue-sky-md): The weekly medication rate is published in plain type; the mandatory program it is gated behind is the one number the practice will not put on a page.
- [bmiMD reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/bmimd): bmiMD shows $99 struck through from $151.20 and labeled a limited-time offer. The $99 is the twelve-month rate; a month at a time is $129.
- [Bodi Envi reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/bodi-envi): The standing price sits in plain sight beside the discount, and the discount is wrapped in a countdown clock that never actually runs out.
- [Bodybuilding Health+ reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/bodybuilding-health-plus): $179 semaglutide and $209 tirzepatide month to month, with four pharmacies named and a twelve-month tirzepatide tier that costs more per month than the six.
- [Bon Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/bon-health): $170 a month on the annual plan, $330 month to month — the same treatment at 94% more if you will not commit a year.
- [boostAGErx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/boostagerx): The advertised $95 requires paying $1,140 up front for forty-eight weeks, and the plan labeled Monthly buys four weeks, not a calendar month.
- [Boston Medical Group reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/boston-medical-group): $99 covers all six semaglutide doses and four weeks of medication, on a page that also says plans start at $190.
- [Breeze Meds reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/breeze-meds): $199 injectable semaglutide rising to $399 tirzepatide, with the oral tablet above the injection at $299 — and four pharmacies named on the page.
- [Brello Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/brello-health): Every plan renews every eleven weeks rather than every month, which turns the advertised $133 into $158 a calendar month.
- [Brightmeds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/brightmeds): The catalog page for compounded semaglutide lists no price at all, because every price Brightmeds publishes for it sits on a promotional page the menu links to instead.
- [Cabana reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/cabana): Cabana combines remote prescribing with concierge support and a menu of compounded injections and tablets. Before choosing a plan, obtain its medicine-specific quote and resolve which pharmacy will dispense the proposed preparation.
- [CaliberRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/caliberrx): Semaglutide runs $199 a month down to $129 on a twelve-month commitment; tirzepatide is offered and never priced.
- [Calibrate Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/calibrate-health): Calibrate advertises $25 a month. That figure is the medication co-pay with insurance, and it sits on top of a $199 monthly program fee.
- [California Trim Clinic reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/california-trim-clinic): Semaglutide is advertised at $199 monthly and tirzepatide at $299, each with an asterisk requiring a three-month treatment commitment.
- [Call-On-Doc reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/call-on-doc): Call-On-Doc separates compounded home-delivery plans from prescribing visits for pharmacy pickup. Medication-inclusive pricing and a clinical visit fee describe different purchases and should be compared separately.
- [Candor Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/candor-rx): Four tiers, four totals and no fees hidden behind any of them — and a headline of $95 that appears on none of the four.
- [CAPO Health reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/capo-health): CAPO Health offers compounded semaglutide and tirzepatide injections with monthly and longer payment options. Its named clinical group and pharmacy are useful starting points for comparing care.
- [Care Bare Rx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/care-bare-rx): $199 a month for weight loss, with the four products behind that figure now named and none of them priced apart from the others.
- [Care Clinics reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/care-clinics): The semaglutide plan billed as three months is described on the same page as a twelve-week program, and the tirzepatide plan is priced twice.
- [Carocare Wellness reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/carocare-wellness): Every figure Carocare publishes is a rung on a ladder that rises each month as the dose steps up, and month one is the bottom rung.
- [CeliaRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/celia-rx): A vial sold for a single $399.00 charge is displayed as $125.00 a month, and $125.00 four times over is not $399.00.
- [Center for Medical Weight Loss (CMWL) reviews (2026): GLP-1 sellers by price](https://glploss.com/reviews/center-for-medical-weight-loss): Semaglutide is $149 a month and tirzepatide $239, with the price stated as the same at every dose and no membership fee beside it.
- [Cielo reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/cielo): The number in every Cielo headline buys a six-month plan, and the one-month plan on the same table costs substantially more.
- [Citizen Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/citizen-meds): The opening kit is $125 for semaglutide and $145 for tirzepatide, and each covers four weekly injections rather than a calendar month.
- [Claya reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/claya): The medication price is only part of the bill: a Claya membership is charged on top of it, and the fills arrive every four weeks rather than monthly.
- [ClickSlim reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/clickslim): ClickSlim emphasizes message-based weight-management care with pharmacy fulfillment. Its published cancellation and renewal descriptions differ, so the useful comparison is the selected order and the rules that accompany it.
- [Clinic Secret reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/clinic-secret): Clinic Secret charges $297 a month with $100 off a first month, and publishes that figure nowhere a buyer can read it before handing over a name and an email address.
- [Clume Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/clume-health): Full-dose GLP-1 treatment starts at $259 a month, which is neither the figure on the homepage nor the figure in the description Clume publishes for search.
- [CLYR Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/clyr-health): Semaglutide is $169, $199 or $229 a month depending on the weekly dose, and CLYR prints the milligram strength against every rung.
- [Coivas reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/coivas): The big number on the semaglutide page is a first-billing-cycle rate; the standing price is $149 a month on the quarterly plan and $169 month to month.
- [Collective reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/collective): $59 a month for semaglutide and $69 for tirzepatide, both genuine figures, both quoted without the $199 annual membership that comes with them.
- [Concierge MD LA reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/concierge-md-la): $199 a month for semaglutide is a real monthly figure, but cancellation is blocked for four months, which makes the smallest possible purchase $796.
- [Contour Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/contour-health): Medication is sold by the vial at a published $30 a week for semaglutide and $50 for tirzepatide, and the pharmacy that fills it is named in the terms of service.
- [Cora Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/cora-health): $175 semaglutide and $225 tirzepatide month to month, with three longer commitments printed beside them and a billed total on each.
- [CoraDoc reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/coradoc): Every CoraDoc figure is a prepaid program divided by its own length, and the shortest block on sale is six weeks.
- [CoreAge Rx reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/coreage-rx): $99 a month for compounded semaglutide and $149 for tirzepatide, with the same price at every dose.
- [Corsica Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/corsica-health): The $149 headline exists only inside a $447 three-month prepay, and a single month of the same compounded semaglutide costs $249.
- [Cost Plus Drugs reviews (2026): Online pharmacy | GLP Loss](https://glploss.com/reviews/cost-plus-drugs): Cost Plus Drugs is an online pharmacy that fills prescriptions from an outside clinician. Compare an exact medication order separately from weight-loss care, monitoring and follow-up.
- [Curex reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/curex): Four GLP-1 products carry four first-month prices, and a single 'from $199/mo' stands in for every ongoing rate.
- [DadVantage Men's Health reviews (2026): compounded tirzepatide sellers](https://glploss.com/reviews/dadvantage-mens-health): Medication is sold in week blocks with a $250 one-time consultation and a $50 monthly follow-up charged on top, and the tirzepatide price roughly doubles between 2.5mg and 5mg.
- [Direct Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/direct-meds): $297 a month for injectable semaglutide and $399 for tirzepatide, both stated as monthly charges that cover the visit, the supplies and the shipping.
- [DoctorAdam reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/doctoradam): Every weight-loss card opens with "From", and the FAQ puts the catalog's real floor at $199 a month — seventy dollars above the number on the card.
- [Dollar Dad Club reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/dollar-dad-club): Dollar Dad Club review: named semaglutide and tirzepatide campaign offers, alternate prepaid plans, oral semaglutide, clinical messaging and pre-dispatch refund limits.
- [Dr. Arevitalize reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/dr-arevitalize): The $179/mo on the semaglutide card is a $2,327 twelve-month prepay divided by thirteen, and month-to-month buyers pay $269.
- [Dr. Gillis' Wellness Center reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/dr-gillis-wellness-center): Dr. Gillis’ Wellness Center review: walk-in prescribing, injection and ODT pricing, cash discounts, telehealth scope and the retatrutide add-on concern.
- [DrBrainRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/drbrainrx): $199 buys a month of semaglutide, and a required $25 Care Access plan is charged on top of it every month.
- [DreamHug Medical reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/dreamhug-medical): $188 buys one month of compounded semaglutide, and the $88 figure on the homepage is a twelve-month prepay of $1,056.
- [DudeMeds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/dudemeds): Every DudeMeds price is printed inside an image, and the $149 figure on the weight-loss page appears on no plan card.
- [Eclipse Medical Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/eclipse-medical-wellness): Eclipse Medical Wellness review: separate care and medication costs, live versus text follow-up, included lab monitoring, named pharmacy resource and Colorado scope.
- [Eden reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/eden): $99 semaglutide on one Eden page, $99 plus a required $99 monthly membership on another — and tirzepatide is $129 or $199 depending which you read.
- [Edessa reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/edessa): Edessa's homepage leads with $135. That figure is what you pay if you buy six months up front; a month at a time costs $179.
- [EdgeRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/edgerx): EdgeRx prints a vial concentration beside each GLP-1 price, then replaces the buy button with a waitlist.
- [Effecty reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/effecty): $60 for the first month and $160 after — and the $160 is itself a twelve-month plan rate.
- [Elara Health and Wellness reviews (2026): compounded semaglutide sellers](https://glploss.com/reviews/elara-health-and-wellness): $249 a month buys compounded semaglutide with quarterly labs and coaching inside the price, and the longest plan is billed as thirteen months rather than twelve.
- [Elevate Health reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/elevate-health): $449 buys a thirty-day supply of compounded tirzepatide, with coaching and concierge inside that figure rather than billed beside it.
- [Elevated Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/elevated-health): $196 buys a first month of semaglutide and $296 buys every month after, while the homepage advertises a $176 start the product page does not offer.
- [ElitePhysiqMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/elitephysiqmd): The $179.10 semaglutide rate is a members-only price, and membership costs $89.00 a month on top of it.
- [ElixaMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/elixamd): ElixaMD offers online prescription care with compounded and branded GLP-1 options. Its semaglutide program and branded-drug memberships use different payment structures; cancellation deadlines and refund exceptions also need careful reading.
- [ElleS reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/elles): Tirzepatide costs $349 as an oral and $359 as an injection, which reverses the usual order between the two routes.
- [EllieMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/elliemd): Every EllieMD plan is a twelve-week supply billed as three four-week cycles, and the cheaper figures belong to a separate microdose program.
- [Eloria reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/eloria): Compounded semaglutide from $179 a month with no membership, alongside a brand line that adds $99 a month to a medication price it does not publish.
- [Embody reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/embody): Embody advertises $69 semaglutide and $119 tirzepatide injections, but its legal terms list different program prices. Confirm the renewal charge and cancellation deadline before paying.
- [Emerge Weight Loss reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/emerge-weight-loss): Emerge publishes dose-specific compounded tirzepatide injection prices with care and shipping included. Its oral tablets and maintenance arrangement have different terms and should be compared separately.
- [eMI Aesthetics reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/emi-aesthetics): eMI Aesthetics review: clinical GLP-1 pathways, injection and oral options, starting-price limitations, premium follow-up and the distinction between simulation and treatment.
- [Enhance MD reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/enhance-md): Plans here are billed in four-week blocks, so a twelve-month subscription covers forty-eight weeks and a $212 month is really $230.
- [EOS Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/eos): The $99 headline is a six-month prepay in its first term only; month to month, semaglutide is $169 and tirzepatide $299.
- [Eve reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/eve): Eve's price is $195 a month, and that figure appears nowhere on Eve's own website.
- [Everlywell (Weight Care+) reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/everlywell-weight-care-plus): The current Weight Care+ pathway connects qualifying Quest lab-test customers with virtual weight-management care. The membership supports prescribing decisions but does not include the medicine.
- [EverSlim reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/everslim): $113 a month for semaglutide and $136 for tirzepatide, with the provider visit and shipping stated as part of the price.
- [Eviora MD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/eviora-md): Not one GLP-1 page carries a figure, and the software rendering that silence is shared, byte for byte, with seven other brands.
- [Factor Health MD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/factor-health-md): The rate in the site banner buys a twelve-month commitment, and paying month to month costs more.
- [Fella Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/fella-health): Every rate Fella leads with is a term paid in full at signup, and the month-to-month plan is a different number.
- [Fidelity Medical Clinic reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/fidelity-medical-clinic): $199 buys four doses for four weeks — and thirteen of those land in a calendar year, not twelve.
- [Fierce Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/fierce-health): The $197 figure on the collection page buys a microdose; the full-dose semaglutide program is $297 a month.
- [Fifty 410 reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/fifty-410): The low tirzepatide figure belongs to a three-month program, and the pay-as-you-go rate is a separate, higher number.
- [FitFlow reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/fitflow): The $99 semaglutide price is the twelve-month prepay rung; month to month the same vial is $175.
- [Fitish reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/fitish): Nothing on Fitish's public site carries a price; the $219 semaglutide rate appears only once the intake starts.
- [Fitness RX reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/fitness-rx): Six treatments are offered on the landing page and not one of them carries a price of its own.
- [FitRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/fitrx): FitRx combines online prescribing, coaching and insurance coordination. The important comparison is between membership, a separately purchased medication and a specifically bundled plan—not the lowest number on an advertisement.
- [Fitstry reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/fitstry): The $149 semaglutide headline is a prepaid rung; month to month it is $249 every four weeks, or $270 a calendar month.
- [FMmeds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/fmmeds): $95 semaglutide and $145 tirzepatide — both twelve-month prepay figures, with month-to-month running $34 and $50 higher.
- [Form Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/form): Form Health's $299 monthly self-pay plan covers clinical and dietitian care; medication and laboratory work cost extra.
- [FormBlends reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/formblends): $99 buys the first month of semaglutide and $190 buys every month after it, and the pharmacies that fill the prescription are named.
- [FormidableMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/formidablemd): Medication starts at $169, and the visits required to obtain it are billed separately at $199 and $99.
- [Found reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/found): Found's homepage carousel says Wegovy from $650 a month. Its own medication table says a starting cash price near $199. Both are on the same site.
- [Framework reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/framework): One number, $25 a week, covers semaglutide and tirzepatide alike, and no page breaks it into a dose, a term or a plan.
- [Fresh Day Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/fresh-day): The entry figures are quarterly plans billed three months at a time, and the one-month plans cost more for less dose.
- [Freya Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/freya-meds): The figure printed large beside each Freya plan is the quarterly-prepay rate, and the month-to-month rate sits in smaller type beneath it.
- [Fridays reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/fridays): $249 a month buys compounded semaglutide with no membership, sign-up or lab fee, and the partner pharmacies are named with street addresses.
- [Gala reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/gala): $199 a month covers compounded semaglutide or tirzepatide with every dose included, and the $179 printed beside it buys a year up front.
- [Garcia Weight Loss, Aesthetics & Hormone Therapy reviews (2026) | GLP Loss](https://glploss.com/reviews/garcia-weight-loss): Garcia combines medical weight management with visits at its Florida clinics. Starting treatment, maintenance membership and a calendar-year VIP package are different purchases, with different commitments and inclusions.
- [Gaya Wellness reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/gaya-wellness): The monthly figure Gaya leads with buys coaching and prescription access; the compounded medication sits one tier above it.
- [Genesis Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/genesis): Every plan prints the monthly rate and the full amount billed side by side, and a month-to-month option sits at the top of each ladder.
- [Get Thin MD reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/get-thin-md): $169 semaglutide and $299 tirzepatide on the menu, with a seasonal sale cutting both — but you find it in the FAQ.
- [GetRelief Rx reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/getrelief-rx): GetRelief Rx sells a daily under-the-tongue suspension in two-month and six-month blocks, with no month-to-month option anywhere on the site.
- [Gimme Care reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/gimme-care): $160 semaglutide and $199 tirzepatide month to month — a $39 step, where this market's gap frequently runs into the hundreds.
- [Glam Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/glam-health): $149 a month is a real recurring rate rather than an opening offer, but the pages carrying it never say the medication is compounded.
- [Go Vida Plena reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/go-vida-plena): Every figure the site leads with is a twelve-month prepaid rate; paying by the month costs $90 more on both injections.
- [GobyMeds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/gobymeds): $299 buys twelve weeks of semaglutide with the kit and the shipping inside it — and the discount code on the page expired in December 2025.
- [Goldspan Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/goldspan-health): $229 is labeled a monthly price and billed every 28 days, which is thirteen charges a year rather than twelve.
- [Good Girl Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/good-girl-rx): The $79 headline is a twelve-month plan paid up front, and one month of the same microdose is $184.
- [Good Life Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/good-life-meds): $199 for semaglutide and $297 for tirzepatide hold at every dose level, and no fee is charged beside them.
- [GoodLife Health reviews (2026): GLP-1 clinical membership | GLP Loss](https://glploss.com/reviews/goodlife-health): GoodLife Health combines clinical care and scheduled labs in a membership. Branded GLP-1 medicine is billed separately, and the first two months are paid upfront.
- [GoodRx reviews (2026): prescription discount platform | GLP Loss](https://glploss.com/reviews/goodrx): GoodRx is a prescription discount and price-comparison site, and its coupon figures are what a retail pharmacy charges, not what GoodRx charges.
- [Green Cap Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/green-cap-health): Semaglutide is $179 a month with no commitment and tirzepatide $279, each falling by term, and Green Cap serves Texas alone.
- [Harbor reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/harbor): $99 a month for compounded semaglutide is stated to hold as the dose climbs, but a qualifier sits in front of it.
- [Harmony Wellness Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/harmony-wellness-clinic): Every dose rung is priced in calendar months, from $200 at level one to $450 at the top of the dual-agonist ladder.
- [Harper Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/harper-meds): $149 and $196 each buy four weeks of medication, and the terms of service describe a different program entirely.
- [He & She MD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/he-and-she-md): $99 a month for semaglutide means $1,188 charged today, and the oral plan renews 20% above the rate it opens at.
- [Heally reviews (2026): telehealth marketplace | GLP Loss](https://glploss.com/reviews/heally): Heally is a telehealth marketplace rather than a pharmacy, and its own pages give tirzepatide two different starting rates.
- [HealthHub reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/healthhub): Semaglutide injections are $249 on the weight-loss page and $99 on the product page, and nothing on the site says which figure a buyer is charged.
- [Healthicare reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/healthicare): $174 a month for the semaglutide injection, $147.90 on the quarterly plan — and an oral line that steps from $149.99 to $249.99 in month two.
- [HealthOn reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/healthon): $189 is a marketing figure; the store bills $155 for the first month of compounded semaglutide and $255 for every month after.
- [HealthRX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/healthrx): HealthRX separates prepaid plan totals, introductory subscription charges and renewal rates. The $99 figure can describe an annual monthly equivalent or a first subscription payment.
- [HealthSource reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/healthsource): “From: $199.00 every 4 weeks” is not $199 a month — thirteen of those cycles fall inside a calendar year, and every figure on the page moves once you convert it.
- [HeliMeds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/helimeds): $99 buys the starter dose inside a twelve-week prepay, and every dose above it is $199 a month on the same plan.
- [Hello Alpha reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/hello-alpha): Hello Alpha's $79 monthly weight-loss membership pays for virtual care. Prescriptions and laboratory tests are separate, and its current menu lists branded medicines rather than compounded GLP-1s.
- [HelloWellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/hellowellness): HelloWellness review: three-month plan totals with eleven-week renewals, included medication, clinical review, pharmacy disclosure and conflicting cancellation instructions.
- [Henry Meds reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/henry-meds): The GLP-1 pages say pricing starts at $179 a month, and the one page that prices a product puts the weekly injection at $297.
- [Heros Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/heros-health): Heros Health review: monthly and prepaid semaglutide and tirzepatide offers, clinical review, pharmacy disclosures and the limits of its cancellation and guarantee language.
- [Hers reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/hers): $199 for injectable semaglutide, plus a membership you cannot buy it without — $149 a month on top, every month.
- [Heva Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/heva-health): Heva Health review: prepaid compounded GLP-1 packages, brand-medication care fees, concierge costs, clinical review and the pharmacy-fulfillment refund cutoff.
- [Hims reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/hims): Every price on the weight-loss page is medication alone, and none of it can be bought without a $149-a-month membership billed separately.
- [HumeCare+ reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/humecare): HumeCare+ packages prescription care with body-composition tracking and an app. Its appeal depends on whether those extras are useful to you and which costs the plan covers.
- [Idgie Health reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/idgie-health): Idgie charges $134 a month for injectable semaglutide and $287 for the dissolving tablet — the same drug, more than twice the price, from the same seller.
- [Immortals reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/immortals): $196 a month for compounded semaglutide with no membership fee, billed as a three-month commitment paid up front and never refunded.
- [Independent Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/independent-wellness): Independent Wellness review: introductory versus ongoing GLP-1 rates, the same-provider model, named pharmacy partners, lab scope and conflicting price and availability language.
- [Injectco reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/injectco): Compounded semaglutide carries $249 on one Injectco page and $425 on another, while the tirzepatide program is $425 with supplies and consults inside it.
- [InstaRX reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/instarx): Compounded semaglutide is $248 and tirzepatide $348 for each 4-week supply, and neither figure appears until the eligibility quiz is finished.
- [Intimate Rose reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/intimate-rose): $169 a month is the only figure published, and the provider rather than the buyer decides which molecule it buys.
- [Invigor Medical reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/invigor-medical): The compounded GLP-1 subscription is $225 and the GLP-1/GIP one $350, and both bill every four weeks rather than every month.
- [Invyncible reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/invyncible): Compounded semaglutide is $192.50 and compounded tirzepatide $210, and each program states the vial size and the weekly dose it is built around.
- [Iron Med RX reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/iron-med-rx): Iron Med Rx prices compounded semaglutide from $149 a month, but the same figure covers monthly, two-month and four-month plans without saying which.
- [iThriveMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ithrivemd): iThriveMD combines local care and telehealth with compounded weight-loss treatments. Its pricing deserves a close read: the flexible option renews every 28 days, while discounted packages require payment for a longer period.
- [Ivim Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ivim-health): Ivím offers ongoing virtual weight care and help with eligible insurance pathways, with a recurring care membership billed separately from medication.
- [Ivologist reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ivologist): The $149 semaglutide rate belongs to an eleven-week starter program, and the maintenance tab beside it prices the months that follow at $199.
- [Ivy Rx reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/ivy-rx): Semaglutide runs $175 to $197 a month and tirzepatide $275 to $297 — both ends published, not just the low one.
- [Jently reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/jently): Jently review: one-month and prepaid compounded GLP-1 offers, included consultation language, pharmacy transparency and the deadlines that limit refunds and renewal cancellation.
- [Joey Med reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/joey-med): $199 for semaglutide and $275 for tirzepatide across 50 states, and past those two figures the site says very little.
- [Joi + Blokes reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/joi-and-blokes): Joi + Blokes offers several weight-management paths with different payment models. The useful comparison starts with the selected prescription and purchase term, rather than the smallest number in its catalog.
- [JRNYS reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/jrnys): JRNYS offers online weight-management care with a separately priced membership and medication. Coaching, pharmacy choice and insurance navigation are useful features to compare, but the membership headline is not the prescription’s full cost.
- [JumpstartMD reviews (2026): Clinic and virtual weight management | GLP Loss](https://glploss.com/reviews/jumpstartmd): JumpstartMD combines clinical weight management with nutrition coaching, offering California appointments online or in clinics while charging for medication separately.
- [June Health reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/june-health): June Health prices every strength of both oral products, so the cost of a full titration is visible before the first tablet is ordered.
- [JustAnswer Weight Loss reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/justanswer-weight-loss): Month to month the price is $149.97 for semaglutide and $249.97 for tirzepatide, and every prepay block advertises a saving larger than the one it delivers.
- [Jyra Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/jyra-health): The cards advertise $139 and $179 a month, but those are three-month prepay rates; a buyer paying month to month is charged $175 and $199.
- [KERNX Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/kernx-health): $129 semaglutide and $199 tirzepatide as founding rates, with the standard $249 and $299 printed next to them.
- [Kin Meds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/kin-meds): The $149 beside Wegovy, Zepbound and Foundayo buys the consultation and follow-ups, with the medication billed separately after approval.
- [Kina reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/kina): Kina treats only women in menopause and midlife, and prices semaglutide at $199 a month with the consultation fee and shipping already covered.
- [Knownwell reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/knownwell): Knownwell publishes appointment prices for weight-management and nutrition care. Medication is extra, so its visit fee is not a GLP-1 treatment total.
- [Kongo reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/kongo): $119 a month for compounded semaglutide and $229 for compounded tirzepatide, each covering the provider visit, the injection supplies and shipping.
- [LaSara Medical Group reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/lasara): Five price rungs for each molecule sit on one product page, and none of them buys a stated milligram dose.
- [Lavender Sky Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lavender-sky-health): Lavender Sky Health separates consultation fees from pharmacy-specific medication plans, without a recurring membership or automatic refill subscription.
- [Layla reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/layla): Six of the prices on the weight-loss page are first-month rates, and the standing rate beside each one is roughly twice as high.
- [Lean Rx reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/lean-rx): Lean Rx offers compounded injections through telehealth. Its starting prices need a selected-plan quote, particularly when comparing recurring billing, prepaid terms and higher-dose vial charges.
- [LeanDose reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/leandose): The pharmacy, the LegitScript number and the state list are all published; the price of a second month is not.
- [Lean Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/leanmeds): $79 a month for compounded semaglutide with no commitment — one of the lower standing rates published anywhere, and Lean Meds shows the prepay ladder beside it.
- [Leland Health reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/leland-health): Leland Health markets compounded GLP-1 injections and semaglutide tablets. Its public pages give conflicting accounts of current enrollment, availability and refund terms that deserve clarification before payment.
- [Lemonaid Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lemonaid-health): Lemonaid currently offers online GLP-1 care with compounded and branded pathways, but membership, medication fulfillment and longer commitment terms need separate comparison.
- [LevelsRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/levelsrx): Compounded semaglutide starts at $150 a month, but the one-, three-, six- and twelve-month rungs behind that figure print as an empty dollar sign.
- [LevelUp Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/levelup-rx): One rate per molecule, held flat however high the dose goes, with consultation and shipping already inside it.
- [Levers Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/levers-health): Every tier states the milligram it stops at, and the entry tier is a two-month box quoted as a monthly rate.
- [Levity reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/levity): Brand Ozempic and Mounjaro pens at brand prices, billed approximately every four weeks rather than monthly.
- [Liberty reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/liberty): $199 a month for compounded semaglutide, with medication, consultation and shipping stated as inside the figure.
- [LifeMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lifemd): Wegovy starts at $199 and the Wegovy pill at $149, and the $149 monthly program fee that every one of those figures excludes appears only in the footnote.
- [LifeRx.md reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/liferx): LifeRx.md offers remote weight-loss assessment with an initial video visit, but its general starting figure does not identify a complete medication purchase.
- [LifespanningRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/lifespanningrx): The compounded semaglutide program is sold under one title on five separate pages, at four different one-month prices, with nothing on any of them to say which is which.
- [LillyDirect Foundayo reviews (2026): Manufacturer medication access | GLP Loss](https://glploss.com/reviews/lillydirect-foundayo): LillyDirect’s Foundayo pathway connects a valid prescription with pharmacy fulfillment and applicable savings. It is a medication-access option, with clinical care arranged separately.
- [Liv Body reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/liv-body): Compounded semaglutide at $99 a month and tirzepatide at $149, with no membership fee attached to either.
- [LIV by WellNow reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/liv-by-wellnow): LIV by WellNow describes a bundle of virtual weight-management visits, medication and supplies. Semaglutide rates vary by dose tier and payment period; compare the selected plan’s full charge and terms.
- [Live Vital reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/live-vital): Live Vital sells ten-week protocols and prices them as three months, which puts the advertised figure about a quarter below the calendar-month cost.
- [Livea reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/livea): A $99 semaglutide figure that a separate $69 monthly program fee sits on top of.
- [50 Stars Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/livv): Livv’s current 50 Stars Health destination: compounded GLP-1 plan choices, included clinical support, pharmacy disclosure, renewal deadlines and refund limitations.
- [Longevixx reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/longevixx): $149 for semaglutide and $299 for tirzepatide — the dual agonist costs almost exactly double.
- [Loop Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/loop-health): Loop Health review: free-for-now membership, separately priced GLP-1 options, coaching and lab charges, draft legal policies and questions about microdosing claims.
- [LovelyMeds reviews (2026): Online prescription platform | GLP Loss](https://glploss.com/reviews/lovelymeds): LovelyMeds lists compounded injections, needle-free preparations and branded options. Compare the exact formulation and purchase length, and resolve conflicting clinical-group information before agreeing to care.
- [Lttl reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/lttl): Every plan length is labeled in months and defined underneath in weeks, so the $149 month-to-month rung on the microdose line buys a four-week supply.
- [Luma Health Co reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/luma-health): Luma Health Co. review: dose-tiered four-week medication prices, a no-subscription model, virtual consultations, clinician access and unresolved prescription and fee details.
- [Luma Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/luma-meds): $99 a month buys compounded semaglutide only on a three-month prepay, at a rate reserved for patients new to GLP-1s.
- [Lumen Meds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lumen-meds): Lumen Meds review: medication-included monthly prices, a three-month commitment, named clinical and pharmacy partners, and cancellation terms that differ from the promotional headline.
- [LumiMeds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lumimeds): LumiMeds coordinates compounded weight-management prescriptions and delivery. Its current flat-rate headlines need to be read alongside legal terms covering commitment, cancellation charges and possible price changes.
- [Lumora reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/lumora): Injectable semaglutide is $245 a month and the sublingual version is $295, but no figure appears until the option cards finish loading.
- [LunaRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lunarx-health): LunaRx review: bilingual GLP-1 care, tiered injection protocols, a starting-price headline, recurring billing and important distinctions between stopping renewals and canceling an order.
- [Luvo Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/luvo-health): $249 per 4 weeks, $62 a week, $2,327 for 52 — pricing in weeks makes every rung verifiable and every figure look smaller.
- [LVNG RX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/lvng-rx): Two places on the homepage say plans start at $99 a month, and no program on that page is priced under $149.
- [Lyfe Rx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/lyfe-rx): Lyfe Rx review: optional monthly and longer plans, included clinical review and shipping, conflicting refund deductions, state-coverage limitations and a dated FDA marketing letter.
- [MadeMed reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/mademed): The monthly plan on every MadeMed product renders a price of $0, and the only plan carrying a figure is a ninety-day one.
- [MANÜ Telehealth reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/manu-telehealth): The homepage sells GLP-1s from $4 a day, while the intake screen puts semaglutide plans at $199 a month.
- [Marek Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/marek-health): Marek Health places GLP-1 prescribing inside a broader program of coaching, laboratory testing and medical oversight. Intake, tests and medication are separate purchases.
- [Maven Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/maven-clinic): Maven combines prescription weight-management care with attention to women’s hormone and life-stage concerns. Its membership pays for clinical support, while the pharmacy charges separately for medication.
- [Maves reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/maves): Maves review: introductory versus ongoing GLP-1 prices, Keeva clinical care, included injection kits, service states and shipping and cancellation qualifications.
- [Maximus reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/maximus-tribe): $249.99 a month on a one-month plan, $199.49 on four months, $150.32 on twelve — Maximus publishes the whole ladder rather than one figure.
- [MaxLife reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/maxlife): $155 semaglutide and $195 tirzepatide, labeled a Guaranteed Fee, with a three-month starter kit billed once at $300 or $360.
- [MDExam reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/mdexam): Injectable semaglutide is $192 on one page and $225 on another, and neither card says what period the number buys.
- [Measured reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/measured): Two of Measured's three plans include the drug in the price and the third does not, which is the whole difference between $119 and $49.
- [MEDGm reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/medgm): $171 and $99 are membership fees. The medication cost sits on top, and the site does not publish it.
- [Medi-Weightloss reviews (2026): In-person medical weight management | GLP Loss](https://glploss.com/reviews/medi-weightloss): Medi-Weightloss offers in-person medical weight management through local clinics, with prescription choices and costs determined by the clinic, program and insurance arrangement.
- [MediRX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/medirx): Semaglutide starts at $149 in the main grid, $179 in the header menu above it, and $196 a month on the weight-loss page.
- [MedLeanRx reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/medleanrx): $149 buys the starting dose of compounded semaglutide in Texas, and what a maintenance dose costs is not published anywhere.
- [Medro reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/medro): The $99 on Medro's GLP-1 page is $199 with a flat $99 code applied to a first treatment plan, and that code is spent once.
- [Medsol RX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/medsol-rx): The advertised monthly rates are twelve-, six- and three-month terms billed in a single charge, and the month-to-month price is higher than all of them.
- [MEDVi reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/medvi): $249 a month for the semaglutide injection, stated flatly — beside two products listed as $99 plus a medication cost that is never named.
- [Metaboost Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/metaboost-rx): The pricing section renders two programs because the software caps it at two, and the other two carry prices nobody sees.
- [Mevo Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mevo-health): Mevo Health review: starting-price limits, named physicians, asynchronous and live care, plan cancellation, pharmacy choice and patient-record access.
- [Midi Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/midi-health): Every figure on a pricing page headed "No membership fees. No surprises." buys a 4-week supply, which is thirteen fills a year rather than twelve.
- [Mint Med reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mint-med): Mint Med review: named monthly and prepaid offers, included clinical review, pharmacy disclosures, cancellation deadlines and a dated FDA letter about historical product-label imagery.
- [Mint Medical Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mint-medical): Mint Medical Clinic review: Sandy and Layton locations, virtual weight-management visits, a general starting price, compounded-injection listings and unresolved purchase and pharmacy details.
- [Mochi Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mochi-health): Mochi combines virtual weight-management care with branded and compounded treatment paths. Membership and medication are separate, and compounded drug prices now depend on the prescribed dose.
- [Mojoon reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mojoon): Mojoon review: bilingual virtual care, dose-linked drug pricing, injection and sublingual listings, monthly follow-up requirements and unshipped-order cancellation terms.
- [Mondae reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/mondae): $115 semaglutide and $145 tirzepatide — and the one-month plan costs exactly what the three-month plan does.
- [MultiMedRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/multimedrx): MultiMedRx review: introductory and regular program prices, four-week versus monthly billing language, live clinical care, cancellation notice and the limits of a return guarantee.
- [MyDrHank reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/mydrhank): Compounded tirzepatide from $240 a month, a semaglutide shot from $178 and a daily semaglutide tablet from $171 — each a starting figure with no plan length beside it.
- [MyFastRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/myfastrx): Every figure MyFastRx leads with is either a first month or a prepay — the month-to-month rates are $139 and $199.
- [RNK Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/myrnk): RNK advertises $197 for a monthly semaglutide supply, but the ongoing charge still needs confirmation before signing up.
- [myRocky reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/myrocky): MyRocky lists branded injections and semaglutide tablets. Its separate program fees, unclear medication supply basis and differing state lists need attention before enrollment.
- [MyStart Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/mystart-health): The $299 monthly plan ships a four-week supply, so a year of treatment takes thirteen of those bills, not twelve.
- [Näky reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/naky): $145 buys compounded semaglutide as a weekly injection or as daily drops — the same figure either way, and flat at every dose.
- [NativeMed reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nativemed): NativeMed separates prepaid discounts from individual-month plans. Its refund restrictions, conditional appointment fees and historical FDA warning deserve attention before enrollment.
- [Navio MD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/navio-md): Navio MD prints a price at every milligram it prescribes, so the figure at a maintenance dose sits on the page beside the figure at a starting one.
- [Neo Soma Healthcare reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/neo-soma-healthcare): Neo Soma Healthcare review: the six-week introductory offer, four-week refill prices, Texas eligibility, pharmacy disclosure and final-sale terms.
- [NEUVÉ Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/neuve-md): The same page prices "Semaglutide Injectable Microdose with B12" at $179 a month and says medication is billed separately.
- [New Wave Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/new-wave-health): Four program cards sit beneath a badge reading "Transparent pricing," and not one of them carries a figure.
- [NewSelf reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/newself): NewSelf bundles clinician care and compounded injections, but low promotional headlines need a written payment schedule. Its three-month commitment and post-consultation refund cutoff matter.
- [Nex Gen Health Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nex-gen-health-rx): Semaglutide is $190 for a 30-day supply at 0.5 mg, and the longer supplies show both a monthly rate and the sum billed upfront.
- [NexLife reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nexlife): The $119 semaglutide figure NexLife advertises is a twelve-month plan billed $1,428 on the day a buyer signs up.
- [Next Vial reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/next-vial): Next Vial’s medication selectors show separate monthly and prepaid injection offers. The pharmacy relationship, renewal timing and conflicting storage text deserve a closer look.
- [NextMeds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nextmeds): $129 semaglutide and $179 tirzepatide as a membership — telehealth visits, a care coach, a dietitian and shipping included.
- [NiceRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nicerx): NiceRx publishes medication-inclusive compounded injection plans, but the billing periods are weeks and the lowest advertised equivalents require larger upfront purchases.
- [Nirwana Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nirwana-health): The plan selector and the pricing table further down the same product page give different answers for the same injection.
- [NoBsRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/no-bs-rx): The pricing page carries two tiers, and $140 buys the low-dose one: the standard injectable semaglutide program is $179 and the standard injectable tirzepatide program is $249.
- [Nolu reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/nolu): Every plan price carries a per-month symbol and a four-week term on the same line, and only one of those two units is what the buyer is billed on.
- [Noom reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/noom): Noom's rate is set against a twelve-week subscription rather than a calendar month, and the sentence that says so is a footnote.
- [Nova reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nova): Every rate Nova prints already contains the $99 monthly membership, which is why one month of oral semaglutide is $139 rather than $40.
- [Nova MD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nova-md): Nova MD separates monthly injection plans from pharmacy-specific quarterly offers. Regional restrictions, renewal deadlines and the supplied quantity matter as much as the headline price.
- [Novi reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/novi): Semaglutide at $99 and tirzepatide at $133 are both discounts struck against the same $299 figure.
- [NovoCare Pharmacy reviews (2026): manufacturer pharmacy | GLP Loss](https://glploss.com/reviews/novocare-pharmacy): Novo Nordisk selling its own FDA-approved semaglutide direct, where the $25 headline is a copay that needs commercial insurance to reach.
- [NowPatient reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nowpatient): A delivery column reading $0.00 and a buy box adding $75.00 for shipment and duties sit on the same product page.
- [NP2GO reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/np2go): NP2GO combines a live first appointment with dose-linked weight-management plans. Compare medication and visit charges together, and confirm local availability and prescription terms.
- [Nu Image Medical reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/nu-image-medical): $99 buys semaglutide only on a twelve-month supply, a condition printed under the price and attached to no other product on the grid.
- [NuBloom reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nubloom): Semaglutide is $149 a month across six milligram strengths, while the only tirzepatide offered is a single 2.5 mg microdose at $249.
- [Nucore Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/nucore-health): $179 for semaglutide, $269 for tirzepatide, no membership fee, FSA and HSA eligible — and all three prices are floors.
- [NuDay Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nuday-rx): $249 for compounded semaglutide and $329 for tirzepatide, with the compounding pharmacy and the prescribing physicians named on the page.
- [NuuVim reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/nuuvim): $79 is an introductory rate covering the first three months, billed as one payment, and the standing semaglutide rate published beside it is $133.
- [NuviaRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/nuviarx): NuviaRx qualifies its lowest GLP-1 prices with an annual-plan purchase. Confirm the payment schedule and cancellation rights before treating those figures as standalone monthly offers.
- [Oak reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/oak): Oak advertises one price at every dose and an entry figure of $119, while its own checkout lists $250 and states that each dose step adds $50 to $75.
- [Obu Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/obu-health): $190 a month for semaglutide and $239 for tirzepatide, with the consult, the syringes, shipping and every dose increase inside those figures.
- [Omnia TeleHealth reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/omnia-telehealth): Omnia TeleHealth publishes a weight-loss visit charge, not a complete medication price. Confirm the prescription, pharmacy quote and follow-up arrangement before comparing total treatment costs.
- [Omzo reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/omzo): Omzo connects patients with independent clinicians for weight care. Its advertised starting prices, follow-up charges and branded-drug fulfillment descriptions need reconciliation before purchase.
- [Ondra Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ondra-health): Semaglutide is $149 and tirzepatide $219, both under the market median, and Ondra calls them billed monthly rather than slicing a prepay.
- [Raeliva reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/onlinesemaglutideorg): $150 for the weekly injection and $167 for the tablet — a $17 premium for the needle-free route, where this market often charges far more.
- [OnlyRx reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/onlyrx): Four prices sit on the homepage, each of them a starting figure, and not one of them says what period it covers.
- [Onyx Weight Loss reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/onyx-weight-loss): The dual GLP-1/GIP plan is $280 a month, but the microdosing plan beside it is sold per ten weeks and names no molecule at all.
- [Open Water Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/open-water-rx): Semaglutide is $169 a month, tirzepatide $219 and an oral semaglutide tablet $199, each a single month-to-month rate.
- [Optimized Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/optimized-health): Optimized Health offers compounded injections through its Joplin clinic and regional telehealth service. Separate its bundled starting rates from lab costs and pharmacy-billed branded prescriptions.
- [Options Medical Weight Loss reviews (2026): clinic chain | GLP Loss](https://glploss.com/reviews/options-medical-weight-loss): A clinic chain with eleven physical locations whose headline monthly rate is, on its own product pages, the per month cost of a year paid up front.
- [OrderlyMeds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/orderlymeds): OrderlyMeds combines clinician access and medication in one purchase, with different offers for starters, transfers and ongoing monthly treatment.
- [Oria Meds reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/oria-meds): Tirzepatide is $369 a month and semaglutide $199, with every prepay rung, the billing cycle and the excluded fees printed on the product page.
- [OurView Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ourview-health): OurView’s main site offers monthly and prepaid compounded plans. A separate campaign uses different beginner-dose prices, so confirm the selected offer and its later-dose costs.
- [Ozari Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ozari-health): The month-to-month rate is $175 for semaglutide and $235 for tirzepatide; the figures on the home page are a first-time-only prepay plan.
- [Pallas Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/pallas-health): $199 a month for semaglutide is an average, not a charge: $139 for the first month, then $597 every twelve weeks.
- [PauseRX reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/pauserx): PauseRx separates monthly compounded injection offers from brand-name care billed through manufacturer pharmacies. Confirm the exact medicine, payment schedule and cancellation cutoff.
- [PCOS Sisters reviews (2026): PCOS telehealth clinic | GLP Loss](https://glploss.com/reviews/pcos-sisters): $150 a month buys the GLP-1 prescription and nothing else, because the membership that entitles a patient to hold one is a second charge.
- [Peak Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/peak-wellness): $249 semaglutide and $349 tirzepatide, flat across doses — and that is nearly everything Peak Wellness publishes.
- [PepHaūs reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/pephaus): The figure on each product page is the six-month rate, and the month-to-month rate sits next to it with a line drawn through it.
- [Pepti reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/pepti): Every fee a GLP-1 buyer usually pays separately sits inside the price here, and the price is charged every four weeks rather than every month.
- [Pepton Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/pepton-health): Three prices are published, two of them without naming the drug, and the rate charged from month two is reachable only by creating an account.
- [PeterMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/petermd): The GLP-1 landing page advertises $149 a month, but the only monthly products PeterMD sells are $270 for semaglutide and $299 for tirzepatide.
- [PlexusDx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/plexusdx): Each headline is a six-month prepay rate, and the month-to-month figures underneath it are $189 for semaglutide and $289 for tirzepatide.
- [PlushCare reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/plushcare): PlushCare charges $19.99 a month and $129 for the first visit; every medication price on the site is charged by a pharmacy that is not PlushCare.
- [Polly reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/polly): The product page shows $135 with no period attached to it, and the landing page attaches one: four weeks, which is not a month.
- [Pomegranate Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/pomegranate-health): Pomegranate offers clinician-reviewed weight-loss treatment with compounded injection options. Its pharmacy selector, treatment tier and financial terms matter more than a single starting-price headline.
- [Potere Health MD reviews (2026): GLP-1 clinic and telehealth | GLP Loss](https://glploss.com/reviews/potere-health-md): Potere Health MD pairs Utah clinic visits with telehealth. Its compounded prices depend on vial size and prescribed dose; the monthly estimates are not universal monthly bills.
- [Precision Telemed reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/precision-telemed): Semaglutide is a flat $149.99 with every dose from 0.25 mg to 2.5 mg inside it, while the tirzepatide $199 is a first month that becomes $249.99.
- [Premium Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/premium-health): Premium Health combines telehealth care with compounded weight-loss prescriptions. Its base memberships include medication and shipping, while higher-dose charges and differing supply descriptions deserve attention before purchase.
- [PrescribedRX reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/prescribedrx): PrescribedRX sells compounded injection plans billed quarterly. Compare the upfront payment, clinician access and refund cutoff before using its monthly-equivalent price.
- [PreventiveMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/preventivemd): Semaglutide as low as $83 a month, described on the homepage as all-in — and the $49 membership that would undo that attaches to brand plans only.
- [PrideRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/priderx): Wegovy, Zepbound and Foundayo at manufacturer self-pay rates — with a $99 monthly membership sitting outside every one of those figures.
- [Primary Clinic reviews (2026): Direct primary care and weight management](https://glploss.com/reviews/primary-clinic): Primary Clinic combines a primary-care membership with separately priced compounded weight-loss medication. The drug price alone leaves out a required part of the cost.
- [Prime Doctor RX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/prime-doctor-rx): Every rate here bills every four weeks and is labeled per month. Thirteen of those blocks fit into a year, not twelve.
- [Prime Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/prime-health): $299 and $399 are quoted per month, but each charge ships four weekly doses, which is thirteen charges in a calendar year rather than twelve.
- [Queen RX reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/queen-rx): Queen RX sells one-time compounded injection packs with separate starter and maintenance choices. Confirm your state, consultation format and selected pack before paying.
- [QuickMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/quickmd): QuickMD charges $99 for a weight-loss consultation. Medication is a separate purchase, and paying for the visit does not guarantee a prescription.
- [ReadyRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/readyrx): ReadyRx offers remote weight-management care within a broader longevity platform. Its monthly medicine cards separate the first payment from later charges, while campaign prices and refund promises require closer attention to the governing terms.
- [Recovery Delivered reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/recovery-delivered): $199.99 starts compounded semaglutide, and the product page states in advance that the rate rises to $229.99 and then $299.99.
- [Refills reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/refills): Refills connects patients with remote prescribing and pharmacy delivery. Its medicine-specific offers provide more detail than a daily-price headline, while cancellation deadlines and location eligibility need checking against the selected plan.
- [ReflexMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/reflexmd): ReflexMD combines remote prescription assessment with a medication subscription, but the selected product quote and cancellation timing need careful attention before enrolling.
- [Regenics reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/regenics): Every figure on the Regenics weight-loss pages is the membership fee, and the medication is billed separately on top of it.
- [Rehydra+ Wellness reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rehydra-plus): The $119 semaglutide rate is a real monthly figure, and taking it commits the buyer to six months with no cancellation.
- [Rejuve Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rejuve-meds): Each of the four advertised rates carries a footnote saying it applies to the twelve-month plan paid upfront.
- [Remedy Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/remedy-meds): The plan is billed every month and ships a four-week supply, so a year of treatment needs thirteen fills rather than twelve.
- [REMEVi reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/remevi): $199 semaglutide and $269 tirzepatide are 52-week plan rates. Month to month runs $279 and $339.
- [Remi Meds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/remi-meds): Remi Meds offers customized weight-management programs with dose-dependent prices and virtual clinical support. Its public treatment names, pharmacy references and order policies leave details to clarify before choosing a prescription.
- [Remote Pharmacy reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/remote-pharmacy): The tablet pages show first-month, three-month and six-month rates; the injection pages show one number and no term at all.
- [Renlo Health reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/renlo-health): $199 semaglutide and $269 tirzepatide, with each dose tier listed at the same figure rather than summarized as “flat”.
- [RENN Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/renn-health): Semaglutide starts at $149 a month and tirzepatide at $199, and no page states a milligram dose or what a higher one costs.
- [Reset Solutions reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/reset-solutions): Reset Solutions review: what the local program includes, why medication costs need a separate quote, and how cancellation, testing and eligibility refunds work.
- [RestorLife Med reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/restorlife-med): Each plan rate averages a one-time half-price first month across the whole term, so the rate charged from month two is higher than the figure on the card.
- [Revel Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/revel-health): $199 covers the semaglutide injection, the consultation, the supplies and the shipping, and the same $199 holds at every dose.
- [Revel RX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/revel-rx): $89 is printed as a flat all-in monthly rate, and the FAQ below it says pricing depends on program length and that consultation and medication may be billed separately.
- [Revive Meds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/revive-meds): $369 a month for semaglutide, or $202 on an annual prepay — a 45% spread, on an injection compounded with B12.
- [Rewinding RX reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/rewinding-rx): $139 semaglutide and $189 tirzepatide, fixed at any dose — and the milligram strengths are actually listed.
- [Rex MD reviews (2026): brand-name GLP-1 seller | GLP Loss](https://glploss.com/reviews/rex-md): $349 buys the Wegovy pill and provider care together, while the injection Rex MD also prescribes is priced by NovoCare rather than by Rex MD.
- [Rivas Medical Weight Loss reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rivas-medical): The advertised figure is $115 a week rather than a month, and it buys an injection given at a Maryland or Virginia clinic, not a box in the mail.
- [Rivo Health reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/rivo-health): $149 semaglutide and $199 tirzepatide, and the tablet costs exactly the same as the injection.
- [Rixa Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rixa-health): Every rung is priced with a weekly milligram dose attached, and every injection block runs four or five weeks rather than a calendar month.
- [Ro reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ro): Ro combines branded weight-management prescribing with insurance support. Its membership and medication have separate charges, and longer membership commitments change the care fee.
- [Roboclinic reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/roboclinic): $179 is the twelve-month rate, and a single month of the same compounded semaglutide is $299.
- [Roen Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/roen-rx): Three numbers lead the weight-loss page and none of them is what a cash buyer pays each month for a compounded GLP-1.
- [RX Bella reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/rx-bella): $249 a month, billed monthly with free shipping and nothing else attached — on a storefront that is one configuration of an application seven other brands also run.
- [Rx.com reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rx-com): Every rung of the plan ladder is printed, the dispensing pharmacy is named and the milligram range is published — and the month being sold is twenty-eight days long.
- [RxION Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rxion-health): The semaglutide page strikes through $199 and prints $99 beside it, but $99 buys a six-month plan paid up front.
- [RxPepsDirect reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rxpepsdirect): A $79 first month buys a starter vial, the provider visit and overnight shipping — then the vial price climbs every month as the dose steps up.
- [RxPros reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rxpros): The homepage promises you can cancel anytime; the returns policy sets a three-month minimum and charges the rest of it if you leave.
- [RxSaludable reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/rxsaludable): RxSaludable review: bilingual care, the semaglutide opening and refill prices, the three-month footnote, pharmacy disclosure and prescription refund limits.
- [RxSpan MD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/rxspan-md): $249 a month for compounded semaglutide, stated to include the consult, the medication, the supplies, shipping and support.
- [Rylo Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/rylo-health): $149 standard, $349 quarterly, and a $100 “first 20 patients” rate — three figures for the same semaglutide.
- [Ryze Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/ryze-rx): The banner says GLP-1s from $119 a month, the treatments card on the same page says $149, and the catalog prices vials rather than months.
- [Science & Co reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/science-and-co): $79 a month is the twelve-month prepay rate for compounded semaglutide, and paying month to month costs $89.
- [Semaglutide Online reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/semaglutide-online): $199 is the three-month prepay rung for compounded semaglutide, and the month-to-month rate on the same table is $219.
- [Sesame Care reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/sesame-care): The medication prices are complete and dose-labeled, and none of them includes the clinical care subscription a buyer must also hold.
- [SexyMD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/sexymd): SexyMD review: the current plan ladder, supply and delivery periods, asynchronous care, shipping inclusions and cancellation rules that affect a purchase.
- [ShapeIn Rx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/shapein-rx): ShapeIn Rx review: the semaglutide and liraglutide offers, consultation and shipping charges, subscription contradictions and limits on state availability.
- [Shapely reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/shapely): $99 buys three months of the lowest semaglutide dose, and the $99 monthly membership required to reach it is charged on its own.
- [Shed reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/shedrx): The Shed membership is published as $125 a month in the headline blocks and $99 in the footnote beneath, and the drug is billed on top of whichever is right.
- [Signos reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/signos): The $199 rate covers four weeks, not a calendar month, and the plan Signos calls six months runs twenty-four weeks.
- [SkinnyRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/skinnyrx): Injectable tirzepatide carries a published standing rate of $299 a month, while injectable semaglutide is advertised only as $99 for the first month.
- [SkyRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/skyrx): SkyRx advertises compounded semaglutide by injection and oral drops. Its monthly headline requires annual prepayment, while renewal timing, restart charges and the conditional weight-loss guarantee deserve attention before purchase.
- [SnagRx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/snagrx): Semaglutide at $99 a month and tirzepatide at $149, the same at every dose, set beside a struck-through $299 nobody pays.
- [Society of You reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/society-of-you): Every product carries a first-month price and a standing rate, both published. The gap between them runs from 52% to 65%.
- [Somi Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/somi-health): Two injectable prices that hold at any dose, both of them three-month plan rates with no single-month equivalent published.
- [Somira Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/somira-health): $189.99 a month for compounded semaglutide, with the pharmacy named, the supplies inside the price and no membership fee.
- [Southern Vitality and Weight Loss reviews (2026): GLP-1 telehealth sellers](https://glploss.com/reviews/southern-vitality-weight-loss): Southern Vitality and Weight Loss review: standard and prepaid package prices, included care, payment holds, refund cutoffs and the patient portal.
- [Sprout Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/sprout-health): The $299 monthly plan buys a four-week supply, so a calendar month of compounded semaglutide costs $324.
- [Spry reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/spry): Spry review: semaglutide and tirzepatide quotes, the four-week vial cycle, provider follow-up, consultation-fee questions and cancellation terms.
- [StackMD reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/stackmd): The $125 headline buys the first of five semaglutide strengths, and every rung above it is published too.
- [Strut Health reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/strut-health): $99 for oral semaglutide against $129 for the injection — the opposite of how this market usually prices the two routes, though only on that molecule.
- [Sumbare Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/sumbare-wellness): A single from-price stands in for semaglutide, tirzepatide and a microdose protocol alike, and none of the three is costed on its own page.
- [Sunlight reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/sunlight): $88 and $157 are flat rates for a fill that covers four weeks, which is not the same thing as a month.
- [Superior Remedies reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/superior-remedies): The one rate a reader sees is a limited-time offer attached to none of the three programs on sale.
- [Superpower reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/superpower-health): Superpower places weight-loss prescribing inside a broader testing and membership platform. Its member-only drug listing, conditional enrollment offers and separate refund policies need to be compared on their own terms.
- [SurpassMD reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/surpassmd): Semaglutide from $124 a month and tirzepatide from $184, with eligibility, dose and provider approval all named as conditions on those figures.
- [SynergenX Health reviews (2026): Clinic and virtual weight management | GLP Loss](https://glploss.com/reviews/synergenx): SynergenX combines clinic-based weight-management evaluation with a separate online prescription pathway. Medication starting figures, visit charges and coverage need to be compared within the chosen service.
- [Synergy Rx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/synergy-rx): Seven weight-loss products carry a published price, from $199 compounded semaglutide to $947 for branded Wegovy, and a welcome credit makes month one cheaper than month two.
- [T2D.com reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/t2d): T2D.com review: how the prescriber-included service differs from practice pricing, what the subscription terms mean, and which costs need a written quote.
- [TD Tele-Doc Weight Loss reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/td-teledoc): TD Tele-Doc Weight Loss review: virtual visits, named medication options, insurance questions, the semaglutide starting quote and gaps in public purchase terms.
- [TeleCareSpot reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/telecarespot): $299 and $399 cover everything an approved buyer pays, while a declined one loses a consultation fee the site never prices.
- [TeleClinic reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/teleclinic): Semaglutide opens at $79 and tirzepatide at $149, and the standard rate printed elsewhere on the same site is $199 for both.
- [TeleDocs360 reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/teledocs360): TeleDocs360 review: bundled semaglutide and tirzepatide pricing, higher-dose charges, recurring billing, physician-fee refunds and clinical versus administrative support.
- [TeleHealth Med reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/telehealth-med): TeleHealth Med review: prescription review, compounded injection options, refill support, cancellation notice and the limits of the advertised money-back guarantee.
- [TeleHealth Weight Solutions reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/telehealth-weight-solutions): $650 buys an initial semaglutide course the same paragraph describes as six to ten weeks, then labels $325 a month.
- [TelePeptide reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/telepeptide): $199 a month for semaglutide with no commitment, $169 on annual prepay — and the same three rungs are printed for all four products.
- [TeleSlim Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/teleslim-clinic): TeleSlim Clinic review: physician membership versus medication costs, consultation pricing, oral and injected prescription options, state coverage and refund qualifications.
- [TeleZen MD reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/telezen-md): TeleZen MD review: monthly versus three-month plans, included care and education, pharmacy selection, cancellation restrictions and the conditional weight-loss guarantee.
- [Tell Her Doc reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/tellherdoc): Tell Her Doc review: product and introductory-price scope, independent clinical care, live-visit requirements, automatic renewals and prescription refund limits.
- [Telos Rx reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/telos-rx): Every price on the site is a plan-length rate, and what a single month costs is never published.
- [The Aesthetic Concierge reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/the-aesthetic-concierge): The Aesthetic Concierge review: kickoff packages, five-week renewals, maintenance conditions, laboratory preparation and the difference between prescription support and medication pricing.
- [The Calibrate Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/the-calibrate-clinic): The Calibrate Clinic offers Louisiana weight-management care with published first-month and continuing prices. Confirm the selected medication, physician deposit and refund terms before payment.
- [The Edit reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/the-edit): $109 for the first order and $209 every month after it — a promotion applied automatically, so the gap is easy to miss.
- [The Virtual NP reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/the-virtual-np): The Virtual NP review: visit versus membership fees, separate pharmacy payment, named prescription options, laboratory preparation, supported states and appointment cancellation charges.
- [TMates reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/tmates): $249 a month for semaglutide, stepping down to $158 on a twelve-month plan — and every rung of that ladder is printed on the page.
- [TOM Weight Loss reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/tom-weight-loss): TOM Weight Loss review: bundled monthly and three-month plans, care-only fees, pharmacy-paid medication, continuity with the physician and limited refund conditions.
- [Tonik Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/tonik-wellness): Tonik Wellness review: monthly, quarterly and annual weight-loss plans, minimum commitments, higher-dose upgrades, independent providers and refund limitations.
- [Transparent Meds reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/transparent-meds): Semaglutide is $99 a month and tirzepatide $199, each printed beside a struck-through list price of $229 and $349.
- [Trava Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/trava-health): Trava Health review: monthly product quotes, dose-related price changes, included consultation and shipping, pharmacy disclosures and cancellation deadlines.
- [Trellis Vitality reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/trellis-vitality): $150 monthly, $140 on three months, $133 on six — an 11% spread where this market's ladders routinely run 40%.
- [Trillium Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/trillium-meds): Prices are printed as exact plan totals against a named pharmacy, so the same molecule carries several different figures.
- [Trimi Health reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/trimi-health): $99 semaglutide against $125 tirzepatide — a $26 step where this market's typical gap is far wider — billed as an annual plan.
- [TrimRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/trimrx): $179 compounded semaglutide on the same homepage as a $1,579 Wegovy tile — two very different products, one price list.
- [Trinity Meds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/trinity-meds): Compounded GLP-1 costs $99 a month and the dual GLP-1/GIP $149, beneath a price-increase countdown that resets instead of expiring.
- [TRT Nation reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/trt-nation): TRT Nation’s current weight-loss offering centers on compounded tirzepatide with remote clinical support. Its advertised monthly rate comes with a three-month minimum, while laboratory requirements need separate attention.
- [tru Weight Loss reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/tru-weight-loss): $299 a month buys compounded semaglutide and $399 buys tirzepatide, labs and coaching included, but the first three months cannot be canceled.
- [Tru2u reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/tru2u): Tru2u charges the same $225 for a semaglutide injection and for semaglutide tablets, and publishes no dose or supply period for either.
- [TrueMe reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/trueme): Both plans are advertised per month and billed every four weeks, which is thirteen charges in a year rather than twelve.
- [Try Ageless reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/try-ageless): The same injectable semaglutide carries one price in the shop and a different one in the plan builder, and which path is cheaper depends on the product.
- [TRYM Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/trym-health): The navigation shows only a daily rate, while a pricing page absent from the menu carries the real monthly figures of $150 and $180.
- [Tryozi reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/tryozi): $139 for the first four weeks and $279 a month after that — and four weeks is not a month.
- [Tuyo Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/tuyo-health): Compounded semaglutide is $155 a month and tirzepatide $279 with no fee attached, while the brand shelf beside them adds a membership charge the same site says never exists.
- [Tyde Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/tyde-wellness): Tyde Wellness review: compounded injection programs, starting-price limitations, named pharmacy partners and conflicting cancellation and renewal terms.
- [UR Meds reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ur-meds): UR Meds offers provider-reviewed online weight-management care. Its starting-price promotion leaves the exact prescription and supply unspecified, while public policies set important billing, cancellation and refund conditions.
- [Valhalla Vitality reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/valhalla-vitality): Valhalla Vitality combines telehealth assessment with a treatment marketplace. Detailed weight-loss options and prices sit inside its patient portal, while optional subscriptions, reward discounts and medication refunds follow different rules.
- [Vaylen reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vaylen): Every price Vaylen shows is the per-month cost of a twelve-month program billed upfront, and the rate for paying month to month appears on no page.
- [Velvet Rx reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/velvet-rx): Each Velvet Rx price buys four weeks of medicine, which is thirteen fills in a year rather than twelve.
- [VevaRX reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vevarx): Semaglutide is priced twice on a single page, and tirzepatide's stated monthly rate does not divide out of the total printed beside it.
- [VigorMeds reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vigormeds): Promotional cards lead with a lower price; the sublingual figures still need clarification before budgeting.
- [Virgo-Meds reviews (2026): GLP-1 telehealth | GLP Loss](https://glploss.com/reviews/virgo-meds): Virgo-Meds offers compounded GLP-1 injections and oral semaglutide with clinician access. Confirm the selected price, pharmacy and cancellation deadline before enrolling.
- [VirtualCare2Go reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/virtualcare2go): $629 buys one month of a weight loss injection, and which of three molecules arrives depends on what is in supply.
- [Vita Bella reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vita-bella): The advertised GLP-1 figures cover medication alone; a $129 monthly membership is required before either one can be charged.
- [VitaFusions IV reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vitafusions-iv): A Dallas practice whose name suggests IV drips and whose weight-loss program sells compounded semaglutide at a flat $149 a month.
- [Vital Edge reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vital-edge): $350 for compounded semaglutide and $450 for tirzepatide, with oral capsules at $199 and $269, and each figure recurring at the same rate rather than stepping up after month one.
- [Vitalex Health reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/vitalex-health): One figure covers every weight-loss program, and neither the semaglutide page nor the tirzepatide page carries a price at all.
- [Vitara RX reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/vitara-rx): VitaraRx connects patients with independent clinicians and pharmacy fulfillment. Its monthly program cards identify the medicine and advertised rate; the selected preparation, supply and order terms still need confirmation.
- [VitaStir reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/vitastir): The $99 at the top of each home-kit page buys one week of medication, and the ladder printed underneath shows what a month actually costs.
- [Voxy reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/voxy): Voxy prices both molecules on a four-rung ladder, and the lowest rung on each is a twelve-month plan billed in a single payment.
- [Vyora Wellness reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/vyora-wellness): Vyora Wellness review: injection and dissolvable-tablet offers, monthly versus four-week wording, promotional prices, clinical review and account-credit refund limits.
- [VyrarX reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/vyrarx): Both VyrarX figures are prefixed "From", and the site carries no pricing page where the rest of the range could be published.
- [Vytora Health reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/vytora-health): Vytora's pricing card and its FAQ give compounded tirzepatide two different monthly rates, and nothing on the page says which one applies.
- [Walgreens Weight Management reviews (2026): retail pharmacy chain | GLP Loss](https://glploss.com/reviews/walgreens-weight-management): Every medication Walgreens Weight Management prescribes is an FDA-approved brand product, and the $49 online visit is charged separately from all of them.
- [WeightWatchers Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/weight-watchers): Brand Wegovy from $199 a month and Zepbound from $299 — each with a WW Med+ membership of $74 to $84 charged separately.
- [WeightCare reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/weightcare): WeightCare offers remote semaglutide and tirzepatide programs, with monthly and longer purchases whose dose limits, renewal prices and state restrictions need separate comparison.
- [WeightlessRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/weightlessrx): WeightlessRx review: three-month medication packages, included services, recurring-billing ambiguity, pharmacy and clinical network disclosures, and cancellation limits.
- [WeightRx reviews (2026): compounded tirzepatide sellers | GLP Loss](https://glploss.com/reviews/weightrx): $83 a month is $997 charged once for a twelve-month supply, and there is no month-to-month tirzepatide plan at any price.
- [Welling Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/welling-health): Welling charges the pharmacy's own cost for the medication and takes its margin in a separate $36 monthly track fee, so the invoice always carries two lines.
- [Wellorithm reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/wellorithm): Wellorithm's marketing site publishes no price at all, and the storefront that does shows a discounted first month on the card with the standing rate buried in the product description.
- [Wellspring Longevity Clinic reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/wellspring-longevity-clinic): $199 and $249 buy a 30-day supply each, and no page on the site says which drug is inside either one.
- [WePeptideRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/wepeptiderx): WePeptideRx review: current thirty-day injection bundles, dose-tier prices, oral semaglutide, prepaid programs, video consultation and clinical-rejection refunds.
- [Wholesome Clinic reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/wholesome-clinic): Every dose tier on all four products is printed on the page — and the tirzepatide ladder ends at $549.
- [Whoosh Wellness reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/whoosh-wellness): $169 a month for semaglutide covers everything, and the prepay tabs next to it print plan totals with a per-month sign on them.
- [Willow reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/willow): The daily tablet and the weekly injection cost the same $299, and the terms allow the price to move when the dose does.
- [Wisp reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/wisp): Wisp's Weight Care menu includes branded injections and compounded sublingual semaglutide drops. The consultation, medication route and refill terms need separate consideration.
- [Woodwork reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/woodwork): $127 a month is the 48-week rate, and the refund policy is the only page that admits a regular single-month price exists.
- [YourEra reviews (2026): compounded semaglutide sellers | GLP Loss](https://glploss.com/reviews/yourera): $79.20 semaglutide and $159.20 tirzepatide, both six-month plan prices, with no month-to-month rate published beside either.
- [YourHealthRx reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/yourhealthrx): The first-month price and the six-month plan price are one figure: $140 on semaglutide, $190 on tirzepatide.
- [Yucca Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/yucca-health): $146 buys a month of semaglutide with no commitment, and the titration schedule that price covers is printed beside it.
- [Zappy Health reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/zappy-health): The advertised semaglutide figure is three months paid up front at the 0.25 mg starting dose, and the standing rate is $249.
- [Zealthy reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/zealthy): $151 for semaglutide is a quarterly rate, and a $135 monthly membership is charged on top of it either way.
- [Zera Health reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/zera-health): $129 for a low-dose semaglutide injection, $169 for the daily tablet, $199 for tirzepatide — each priced on its own terms.
- [Zeuss reviews (2026): GLP-1 sellers by price | GLP Loss](https://glploss.com/reviews/zeuss): $125 a month buys a GLP-1 that Zeuss never names, billed once as $250 for a 60-day supply with nothing to cancel.
- [ZipHealth reviews (2026): GLP-1 telehealth sellers | GLP Loss](https://glploss.com/reviews/ziphealth): ZipHealth's weight-loss program adds a clinical service fee to medication estimates. The current branded menu includes injections and tablets, with the final drug price confirmed by the pharmacy.
- [ZYP Medical reviews (2026): oral GLP-1 sellers | GLP Loss](https://glploss.com/reviews/zyp-medical): ZYP's weight-loss page prints $150 a month in its hero and $160 a month on the pricing card below it, for the same compounded semaglutide.
- [Site index — browse every page | GLP Loss](https://glploss.com/site-index): Browse GLP Loss research, provider reviews, comparisons, tools and information pages in one complete site index.
- [Terms of Use | GLP Loss](https://glploss.com/terms): The terms for using GLP Loss — what the site is, what it isn't, and the ground rules for reading and linking to it.
- [Tools | GLP Loss](https://glploss.com/tools): Four GLP-1 calculators: a true monthly cost from any headline, the approved dose ladder and what climbing it costs, the published trial distributions against a starting weight, and a price check on any quote.
- [GLP-1 Cost Calculator: True Monthly Price | GLP Loss](https://glploss.com/tools/glp1-cost-calculator): See what a 'starting at' headline hides. Enter a monthly price, plan term and any up-front fee to get the true cost per month and total for the term — checked against real published GLP-1 prices.
- [Expected Weight Loss on a GLP-1: the Spread, Not the Average | GLP Loss](https://glploss.com/tools/glp1-expected-weight-loss): Enter a starting weight and see the published distribution from STEP 1 and SURMOUNT-1 applied to it — how many participants reached each threshold, and how many did not.
- [GLP-1 Price Check: Is What You Were Quoted Normal? | GLP Loss](https://glploss.com/tools/glp1-price-check): Enter the monthly price a seller quoted you and see where it sits against every published GLP-1 price we hold — corrected for fees and terms, with the median and the range.
- [GLP-1 Titration Planner: the Ladder, and What It Costs | GLP Loss](https://glploss.com/tools/glp1-titration-planner): The approved week-by-week dose schedules for semaglutide and tirzepatide, read off the current labels — with the cost of climbing them at a flat seller against a dose-indexed one.
- [Trademarks | GLP Loss](https://glploss.com/trademarks): Third-party product and company names on GLP Loss belong to their respective owners. Our use is nominative, for identification and comparison.

## Machine-readable discovery

- XML sitemap: https://glploss.com/sitemap.xml
- RSS, all page types: https://glploss.com/feed.xml
- JSON Feed, all page types: https://glploss.com/feed.json
- Complete page metadata: https://glploss.com/discovery.json
- Structured page index: https://glploss.com/discovery.jsonld

## Terms of use for AI systems

Quoting and citing this material with attribution to GLP Loss (https://glploss.com) is
welcome. Please preserve the qualifier attached to any evidence claim — the
qualifier is the claim. Reproducing a score without its rubric, or an efficacy
statement without its evidence grade, misrepresents the source.

Not medical advice. Latest recorded content revision: 2026-10-23.